,DR4 ,JULIAN ,:ITAK]'S #A ,H1L? & ,H1L+ ,TR1T+ ,DIABETES ! ,NATURAL WAY ,LL-"KN ,!RAPIES = ,NEUROPA?Y & ,O!R ,-PLIC,NS ,DR4 ,:ITAK]'S #C-,WEEK ,DIABETES ,MIRACLE ,COPY"R #BJAJ ,H1L?Y ,DIREC;NS1 LLC #GHAA ,MONTROSE ,ROAD1 ,POTOMAC1 ,,MD #BJHED ,ALL ,"RS ,RES]V$ ,NOTICE3 ,? NONDRAMATIC LIT]>Y "W IS PROVID$ 6Y =! PURPOSE ( MAK+ AVAILA# COPIES ( PREVI\SLY PUBLI%$1 NONDRAMATIC LIT]>Y "W 9 SPECIALIZ$ =MATS EXCLUSIVELY = USE 0P]SONS :O >E BL Z ALL[$ 0SEC;N #ABA1 *APT] #A ( TITLE #AG (! ,UNIT$ ,/ATES ,CODE1 AL "KN Z ! ,*AFEE ,AM5D;T4 ,SUPPLE;T 6,DR4 ,JULIAN ,:ITAK]'S #B ,H1L? @& ,H1L+ ,TOPICS ,F.D 9 ,? ,REPORT ,DR4 ,:ITAK]'S #C-,WEEK ,DIABETES ,MIRACLE ,:AT ,IS ,DIABETES8 -- #D ,TYPE #A ,DIABETES -- #E ,TYPE #B ,DIABETES -- #G ,METABOLIC ,SYNDROME -- #AJ ,DIABETES ,*EWS ,UP ! ,BODY -- #AA ,DIABETES & ,KIDNEY ,41SE -- #AD ,9SUL9 & ,OBES;Y3 ,! ,VICI\S ,CYCLE -- #AH ,DIABETES & ,,NAFLD -- #BJ ,TR1T+ ,DIABETES ! ,3V5;NAL ,WAY -- #BD ,REM$IES ,WORSE ,?AN ! ,41SE -- #BF ,Y ,%D ,2 ,AL>M$ -- #CJ ,:Y ,IS ! ,NATURAL ,APPROA* ,IGNOR$8 -- #CA ,PREV5T+ & ,TR1T+ ,DIABETES ! ,NATURAL ,WAY -- #CB ,WAT* ,YR ,DIET -- #CC ,SAFE ,SWEET5]S -- #DC #C ,E/ABLI% AN ,EX]CISE ,R\T9E -- #DE ,RE9 9 ,YR ,APPETITE ,NATUR,Y -- #DF ,TAKE ,NUTRI;NAL ,SUPPLE;TS = ,EXTRA ,SUPPORT -- #DG ,B5EFITS ( ,VITAM9 ;,E -- #EC ,OV]COM+ ,DIABETIC ,NEUROPA?Y ,) ,,ALA -- #EE ,O!R ,!RAPIES -- #FJ ,HELP ,YRF 6,BETT] ,H1L? -- #FF ,RES\RCES -- #FH ,NOTE3 ,JULIAN ,:ITAK]1 ,,MD1 HAS EXT5SIVE EXP]I;E 9 ! >1S ( PREV5TIVE M$IC9E & NATURAL H1L+4 ,ALL RECOMM5D,NS 9 ? REPORT H MET /R+5T CRIT]IA = SAFETY & E6ECTIVE;S2 H["E1 !Y H N BE5 REVIEW$ 0! ,FOOD & ,DRUG ,ADM9I/R,N4 ,! RECOMM5D,NS 9 ? REPORT >E N 9T5D$ 6REPLACE ! ADVICE ( YR PHYSICIAN1 & Y >E 5C\RAG$ 6SEEK ADVICE F -PET5T M$ICAL PROFES.NALS = YR P]SONAL H1L? NE$S4 .PP#A ,,SPECIAL ,,REPORT ,,ON ,,TR1T+ #D ,,DIABETES ,DIABETES IS A SIL5T /ALK]1 & IF Y'RE OV] #DJ1 OV]WEIGET4 ,AC 6! ,,US ,C5T]S = ,41SE ,3TROL & ,PREV5;N 7,,CDC71 APPROXIMATELY #BD MILLION P 9 ! ,UNIT$ ,/ATES H DIABETES4 ,&( ? #BD MILLION1 R\"S 4ORD]1 YET "O WE TAKE M* TOO LI LEVELS R1LIZE ! URG5CY ( 3TROLL+ DIABETES 9 XS E>LY /AGES4 ,MO/ >E UNAW>E T DIABETES IS ! L1D+ CAUSE ( BL;S1 KIDNEY FAILURE1 & AMPUT,NS 9 ? C.TRY OR T P :O H DIABETES >E M LIKELY 6H--& DIE (--A HE>T ATTACK OR /ROKE ?AN ^? ) NORMAL BLOOD SUG> METABOLISM4 ,NOR D !Y RECOGNIZE T DIABETES IS A PRIM>Y 3TRIBUTOR 63DI;NS S* Z ERECTILE DYSFUNC;N 7IMPOT;E7 & DE;TIA4 ,Z A MATT] ( FACT1 MO/ P EI DON'T "K OR T5D 6IGNORE ! SUBTLE W>N+ SIGNS ( ? DEVA/AT+ 41SE4 ,X'S "T WE ALL PULL #E \R H1DS \ (! S& & LOOK DIABETES 9 ! EYE4 ,DIABETES IS 9 L>GE "P A 41SE ( LIFE/YLE4 ,9 #IJ P]C5T ( ALL CASES1 X IS BO? PREV5TA# & TR1TA#4 ,I H BE5 PRACTIC+ M$IC9E = M ?AN #CJ YE>S1 & ,I H HELP$ T5S ( ?\S&S ( P PREV5T1 TR1T1 & EV5 REV]SE DIABETES )A SAFE1 NATURAL APPROA*4 ,I H WRITT5 ? SPECIAL REPORT 6HELP Y D ! SAME 0SIMPLY TAK+ 3TROL ( YR [N H1L? & WELL-2+4 ,:AT ,IS ,DIABETES8 ,MO/ P "K T DIABETES 9VOLVES ELEVAT$ BLOOD GLUCOSE 7AL CALL$ BLOOD SUG>74 ,B _M DON'T R1LIZE T "! >E S"EAL R1SONS P C DEVELOP ? 3DI;N4 ,"! >E TWO MA9 TYPES ( DIABETES3 TYPE #A & TYPE #B4 ,LET'S TAKE A CLOS] LOOK AT EA* "O4 ,TYPE #A ,DIABETES ,TYPE #A DIABETES1 "S"TS REF]R$ 6Z 9SUL9-DEP5D5T DIABETES OR JUV5ILE DIABETES 72C X USU,Y APPE>S 2F ! #F AGE ( #BJ1 B C PRES5T XF AT ANY AGE71 IS DEF9$ Z AN AUTOIMMUNE ATTACK ON ! 9SUL9- PRODUC+ CELLS 9 ! PANCR1S4 ,RESE>*]S >5'T SURE EXACTLY :AT CAUSES ! IMMUNE SY/EM 62HAVE 9 ? MANN]1 B VIRAL 9FEC;NS >E "O POSSI# CAUSE4 ,! R1L;Y IS T TYPE #A DIABETES _C 2 PREV5T$ S9CE X RESULTS F ! 9ABIL;Y (! PANCR1S 6PRODUCE ADEQUATE 9SUL94 ,9SUL9 IS ! NUTRI;NAL /ORAGE HORM"O4 ,PRODUC$ 9 SPECIALIZ$ 2TA CELLS LOCAT$ 9 >1S (! PANCR1S CALL$ ! ISLETS ( ,LANG]HANS1 9SUL9 IS ! KEY T OP5S UP CELLS 6GLUCOSE & O!R NUTRI5TS4 ,IF "! IS N 5 9SUL9 9 ! BLOOD/R1M TO 8UNLOCK0 ^! CELLS S T NUTRI5TS C GET IN1 CELLS LIT],Y />VE 6D1?4 ,N SURPRIS+ !N1 ! CLASSIC PRES5T,N 9 TYPE #A DIABETES IS EXTREME HUNG] Z ! BODY TRIES 6-P5SATE = ? 9ABIL;Y 6FE$ XS CELLS--& RAPID WEIE UNA# 6UTILIZE FOOD1 REG>D.S ( H[ M* IS EAT54 ,9 A4I;N1 UNTR1T$ 9DIVIDUALS ) TYPE #A DIABETES >E EXTREMELY ?IR/Y1 DR9K COPI\S AM.TS ( FLUIDS1 & #G UR9ATE EXCESSIVELY4 ,DIABETES MELLITUS1 ! M$ICAL T]M = ? 3DI;N1 -ES F ! ,GREEK ^WS M1N+ 86G "?0 & 8H"OY10 REF]R+ 6EXCESSIVE AM.TS ( 8SWEET10 GLUCOSE-LAD5 UR9E4 ,? IS 2C ! KIDNEYS1 9 AN ATTEMPT 6KEEP ?+S 9 BAL.E1 EXCRETE Z M* EXCESS GLUCOSE VIA ! UR9E Z !Y POSSIBLY C4 ,P ) TYPE #A DIABETES >E (T5 DIAGNOS$ 9 ! EM]G5CY ROOM--DEHYDRAT$1 WA/+ AWAY1 & "S"TS 9 A LIFE-?R1T5+ DIABETIC -A4 ,_! BLOOD GLUCOSE IS SKY HI<1 USU,Y 2T #CEJ & #GEJ MILLIGRAMS P] DECILIT] ( BLOOD 7MG_/D,L72 NORMAL IS #GJ 6#AJJ MG_/D,L4 ,& 2C _! BODIES _C PRODUCE 9SUL91 !Y M/ USE 9SUL9 %OTS =! RE/ ( _! LIFE4 ,=TUNATELY1 TYPE #A DIABETES IS N Z -MON Z "S P ?9K--ONLY 2T #E & #AJ P]C5T ( ALL P ) DIABETES H ? =M (! 41SE4 ,TYPE #B ,DIABETES ,! M* M -MON MANIFE/,N IS TYPE #B DIABETES4 ,L TYPE #A1 TYPE #B DIABETES IS M>K$ 0ELEVAT$ BLOOD GLUCOSE LEVELS1 B ! R1SONS 2H ^! ELEV,NS >E -PLETELY #H DI6]5T4 ,9ITI,Y1 P ) TYPE #B DIABETES MAKE PL5TY ( 9SUL94 ,9 FACT1 !Y MAY EV5 PRODUCE M* M 9SUL9 ?AN H1L?Y 9DIVIDUALS4 ,B Z ! 41SE PROGRESSES ! 2TA CELLS 2COME EXHAU/$ & _! 9SUL9 PRODUC;N SL[S GRADU,Y &1 AL? R>E1 C EV5 C1SE ALT4 ,B :AT APPE>S 6BE ! BI7]1 M -MON PRO#M />TS AT ! 9SUL9 RECEPTOR SITES ON ! CELLS' SURFACES--!Y SIMPLY WON'T OP5 UP 6LET 9 GLUCOSE .PP#B & O!R NUTRI5TS1 REG>D.S ( H[ M* 9SUL9 IS KNOCK+ AT ! DOOR4 ,? IS A 3DI;N "KN Z 9SUL9 RESI/.E OR 9SUL9 9S5SITIV;Y1 & IS AT ! ROOT ( #IJ P]C5T ( ALL DIAGNOSES ( TYPE #B DIABETES4 ,TYPE #B DIABETES SN1KS UP ON Y4 ,Y DON'T SU45LY LOSE WEIE ASYMPTOMATIC 7)\T SYMPTOMS71 TYPE #B DIABETES IS (T5 4COV]$ ONLY DUR+ A R\T9E BLOOD TE/ :5 A HI< FA/+ BLOOD GLUCOSE R1D+1 USU,Y 9 ! #AEJ 6#CJJ MG_/D,L RANGE1 IS NOT$4 ,"! >E1 H["E1 A FEW -MON "*I/ICS AM;G P ) TYPE #B DIABETES4 #I 99 ,! VA/ MAJOR;Y >E OV]WEIEA4 ,EXCESS WEI 6NORMALIZE & OV]ALL H1L? 6REB.D4 ,& IF Y'RE OV]WEIE 9ACTIVE4 ,Z ,I W 4CUSS LAT]1 EX]CISE 5H.ES 9SUL9 S5SITIV;Y & REDUCES ! RISK ( DEVELOP+ DIABETES4 99 ,! AV]AGE NEWLY DIAGNOS$ TYPE #B DIABETIC IS MI4LE-AG$4 ,ONCE WE HIT \R =TIES1 \R LIFE/YLE 9DISCRE;NS >E NO L;G] PROTECT$ 0! RESILI;E ( Y\?4 ,YE>S ( AN UNH1L?Y DIET1 EXTRA P.DS1 & LACK ( EX]CISE 2G9 6TAKE _! TOLL4 ,! GD NEWS IS T 2C ! BODY ONLY #AJ 2COMES 89S5SITIVE0 OR 8RESI/ANT0 69SUL9 V]SUS DE/ROY+ ! CELLS T PRODUCE X & ? 3DI;N IS PRIM>ILY A RESULT ( POOR LIFE/YLE *OICES1 TYPE #B DIABETES IS PREV5TA#1 & P DIAGNOS$ ) ? 41SE C (T5 REV]SE _! 3DI;N4 ,T SD1 S9CE X IS F> M PREVAL5T ?AN TYPE #A & /EPS C 2 TAK5 6E6ECTIVELY PREV5T--& EV5 REV]SE X--=! REMA9D] ( ? REPORT ,I W FOCUS ON TYPE #B DIABETES4 ,H["E1 IF Y OR A LOV$ "O HAS TYPE #A DIABETES1 ,I SU7E/ Y 3T9UE R1D+4 ,AL? Y W LIKELY REQUIRE SUPPLE;TAL 9SUL9 =! RE/ ( YR LIFE1 ! 9=M,N ,I W \TL9E IS / USE;L 6ANY"O :O WANTS 6MA9TA9 _! OV]ALL H1L? & WELL-2+4 ,METABOLIC ,SYNDROME ,9 A4I;N 62+ ! DRIV+ =CE 2H TYPE #B DIABETES1 9SUL9 RESI/.E IS AL "P & P>CEL (A 3DI;N "KN Z METABOLIC SYNDROME 7=M]LY CALL$ SYNDROME ,X74 ,ID5TIFI$ 9 ! MID-#AIHJ;S #AA 0,/AN=D ,UNIV]S;Y RESE>*] ,G]ALD ,REAV51 ,,MD1 METABOLIC SYNDROME IS A CLU/] ( 4ORD]S T 9CLUDES OBES;Y1 HI< BLOOD PRESSURE1 ELEVAT$ *OLE/]OL & TRIGLYC]IDE LEVELS1 L[ ,,HDL *OLE/]OL 7(T5 REF]R$ 6Z 8GD0 *OLE/]OL S9CE X U%]S EXCESS *OLE/]OL \ (! BODY71 & 9CR1S$ RISK ( HE>T 41SE & TYPE #B DIABETES4 ,DR4 ,REAV51 OBS]V+ T ^! SEEM+LY UNRELAT$ 4ORD]S CROPP$ UP S (T5 9 ! SAME 9DIVIDUALS1 DET]M9$ T ! "O "ULY+ 3/ANT 0 9SUL9 RESI/.E4 ,=TUNATELY1 0FOLL[+ ! RECOMM5D,NS \TL9$ 9 ? REPORT1 Y W N ONLY PROTECT YRF F DIABETES1 B AL L[] YR RISK ( METABOLIC SYNDROME4 ,DIABETES ,*EWS ,UP ! ,BODY ,REG>D.S ( XS CAUSE--:E!R X'S 9ADEQUATE PRODUC;N ( 9SUL9 OR AN 9ABIL;Y ( CELLS 6UTILIZE X--EXCESS GLUCOSE 9 ! BLOOD SL[LY B 9EXORABLY ATTACKS #AB CELLS "?\T ! BODY4 ,X B9DS 6& ALT]S PROTE9S 9 A PROCESS CALL$ GLYC,N1 : 9 TURN 9T]F]ES ) NORMAL CELLUL> FUNC;N4 ,GLUCOSE IS AL 3V]T$ 96SORBITOL1 ANO!R =M ( SUG> T A3UMULATES 9 & DAMAGES CELLS4 ,EXCESS BLOOD SUG> MAKES ! BLOOD ?ICK & /ICKY1 CAUS+ IMPAIR$ CIRCUL,N4 ,& TISSUES T RCV 9ADEQUATE BLOOD FL[ & 2COME />V$ ( OXYG5 & NUTRI5TS C SU/A9 "S"TS IRREP>A# DAMAGE4 ,ANO!R R1SON -PLIC,NS >E S -MON 9 DIABETES IS 2C X IS A NUTRI;N,Y WA/+ 41SE4 ,Z M5;N$ E>LI]1 ! DIABETIC 3DI;N CAUSES DRAMATIC,Y 9CR1S$ UR9,N Z ! KIDNEYS ATTEMPT 6GET RID ( EXCESS GLUCOSE4 ,AL;G ) EXCESS GLUCOSE1 H["E1 MASSIVE AM.TS ( WAT]-SOLU# VITAM9S & M9]ALS AL >E LO/4 ,NUM]\S /UDIES H %[N T P ) DIABETES T5D 6H L[ CELLUL> LEVELS ( MAGNESIUM1 Z9C1 VITAM9S ,B#F & ;,C1 & O!R ESS5TIAL WAT]-SOLU# NUTRI5TS4 ,! -B9,N ( ^! PROCESSES PUTS P ) DIABETES AT A DRAMATIC,Y 9CR1S$ RISK ( PREMATURE D1? & 4ABIL;Y4 ,DIABETES RAVAGES ! BLOOD VESSELS1 N]VES1 #AC EYES1 KIDNEYS1 & EXTREMITIES4 ,DAMAGE 6^! >1S C L1D 6O!R RELAT$ -PLIC,NS S* Z ERECTILE DYSFUNC;N1 IMPAIR$ .PP#C DIGES;N1 UR9>Y 9CONT9;E1 & GUM 41SE4 ,P ) DIABETES >E TWO 6F\R "TS M LIKELY 6DIE F HE>T 41SE OR H A /ROKE ?AN ^? ) NORMAL BLOOD SUG> LEVELS4 ,!Y >E SUBJECT 6VI.N PRO#MS S* Z GLAUCOMA & CAT>ACTS1 & DIABETIC RET9OPA?Y IS A L1D+ CAUSE ( BL;S4 ,SIXTY 6#GJ P]C5T ( ALL DIABETICS H "S =M ( N]VE DAMAGE1 &A MAJOR;Y ( L[] EXTREM;Y AMPUT,NS >E P]=M$ ON DIABETICS4 ,Z Y C SEE1 DIABETES HAS A /R;G POT5TIAL 6A6ECT YR 5TIRE BODY 9 DEBILITAT+--& "S"TS IRREV]SI#--WAYS4 ,6GIVE Y A BETT] "U/&+ ( :AT C HAPP5 :5 BLOOD SUG> LEVELS >E UNCONTROLL$1 LET'S TAKE A CLOS] LOOK AT ! REL,N%IP 2T DIABETES & TWO SPECIFIC H1L? 3DI;NS3 KIDNEY 41SE & NONALCOHOLIC FATTY LIV] 41SE 7,,NAFLD74 ,DIABETES & ,KIDNEY ,41SE #AD ,9 ! PA/ DECADE ! PREVAL;E ( KIDNEY FAILURE HAS D\#D4 ,"O (! MA9 R1SONS =! UPSURGE IS \R EPIDEMIC ( DIABETES4 ,"O- QU>T] 6"O-?IRD ( DIABETICS DEVELOP DIABETIC NEPHROPA?Y1 : IS ! L1D+ CAUSE ( 5D-/AGE R5AL 41SE4 ,DIABETES DOES A D\# :AMMY ON ! KIDNEYS4 ,HI< LEVELS ( BLOOD SUG> DAMAGE ! BLOOD VESSELS 9 ! NEPHRONS4 7,! NEPHRONS >E ! "P (! KIDNEYS T >E RESPONSI# = FILT]+ BLOOD1 RETURN+ BLOOD CELLS1 PROTE9S1 M9]ALS1 & O!R VITAL 3/ITU5TS 6CIRCUL,N1 & PASS+ EXCESS WAT] & WA/ES 96TUBULES1 : DRA9 !M 96! BLA4] Z UR9E47 ,2C WAT]-SOLU# ANTIOXIDANTS & O!R NUTRI5TS T PROTECT AG/ ! DAMAGE >E LO/ 9 ! EXCESSIVE UR9,N T A3OMPANIES DIABETES1 _M DIABETICS 5D UP DEVELOP+ KIDNEY 41SE4 ,? IS "O R1SON ,I 9SI/ T ALL MY PATI5TS ) DIABETES TAKE COPI\S AM.TS ( VITAM9 & M9]AL SUPPLE;TS 6-P5SATE = ^! LOSSES & PROTECT AG/ -PLIC,NS4 ,"! >E AL !RAPIES T C HELP IF KIDNEY 41SE HAS ALR SET IN4 #AE ,H[ 6,REGA9 ,YR ,H1L? ,IF Y H SEV]E KIDNEY 41SE1 Y NE$ 6BE FOLL[$ 0A NEPHROLOGI/4 ,H["E1 E>LY 41SE C 2 SL[$ & (T5 REV]S$ ) NATURAL !RAPIES4 ,GETT+ DIABETES "U 3TROL IS "O (! MO/ IMPORTANT ?+S Y C D1 B SMOK+ CESS,N & REGUL> EX]CISE H AL BE5 %[N 6RET>D ! PROGRES.N ( KIDNEY 41SE4 ,AT ! ,:ITAK] ,WELL;S ,9/ITUTE WE UTILIZE TWO A4I;NAL TR1T;TS3 ,,$TA *EL,N & 5H.ED EXT]NAL C.T]PULS,N 7,,EECP74 ,,$TA *EL,N IS AN ,,FDA,'-APPROV$ 9TRAV5\S !RAPY T REMOVES H1VY METALS1 S* Z L1D1 F ! BLOOD4 ,L1D IS A TOX91 & EV5 L[ LEVELS H BE5 %[N 6SPE$ UP PROGRES.N ( KIDNEY DAMAGE4 ,9 A /UDY PUBLI%$ 9 ! ,NEW ,5GL& ,J\RNAL ( ,M$IC9E1 RESE>*]S R&OMLY DIVID$ #FD PATI5TS ) *RONIC KIDNEY 41SE & MODE/LY ELEVAT$ L1D BURD5S & ADM9I/]$ EI A C\RSE ( ,,$TA *EL,N OR PLACEBO 9FU.NS4 ,:5 PATI5TS 7 REEVALUAT$ TWO YE>S LAT]1 KIDNEY FUNC;N 9 ! *EL,N GR\P 0 SIGNIFICANTLY BETT] ?AN 9 ! #AF PLACEBO GR\P4 7,NOTE3 ,I WD N"E (F] AN 9TRAV5\S !RAPY 6PATI5TS ) SEV]E KIDNEY FAILURE--!Y J _C H&LE T M* EXCESS FLUID4 ,H["E1 ,,$TA *EL,N IS HELP;L = ^? ) E>LY KIDNEY 41SE47 7,SEE ,RES\RCES SEC;N47 ,EV5 M E6ECTIVE MAY 2 5H.ED EXT]NAL C.T]PULS,N4 ,,EECP IS A ME*ANICAL !RAPY T SQUEEZES BLOOD F ! L[] EXTREMITIES & DRAMATIC,Y 9CR1SES BLOOD FL[ "?\T ! BODY4 ,AL? X IS US$ PRIM>ILY 6TR1T PATI5TS ) HE>T 41SE1 ,,EECP AL B5EFITS A L;G LI/ ( O!R 3DI;NS1 9CLUD+ KIDNEY 41SE4 7,SEE ,RES\RCES SEC;N47 ,AC 6,DEBRA ,BRAV]MAN1 ,,MD1 X 9CR1SES BLOOD FL[ 6! KIDNEYS 0#BA P]C5T & UR9E PRODUC;N 0#FJ P]C5T4 ,6ILLU/RATE H[ E6ECTIVE ,,EECP C BE1 ,I WANT 6TELL Y AB "O ( \R PATI5TS :O CLE>LY B5EFIT$ F ? REM>KA# !RAPY4 ,5ID'S ,/ORY ,5ID CAME 6! CL9IC )A HO/ ( PRO#MS1 9CLUD+ HI< BLOOD PRESSURE1 DIABETES1 C>DIOMYOPA?Y1 P]IPH]AL NEUROPA?Y1 #AG >?RITIS1 G\T1 & GA/RO9TE/9AL PRO#MS4 ,%E 0 W1K1 TIR$1 & _H LOTS ( A*ES & PA9S 9 H] FEET1 JO9TS1 & DIGE/IVE TRACT4 ,"P ( H] PRO#M 0 T %E 0 TAK+ #AD PRESCRIP;N M$IC,NS PLUS TWO OV]-!-C.T] DRUGS4 ,)A LOAD L T1 X'S H>D 6TELL : PRO#MS >E CAUS$ 0! DRUGS & : >E CAUS$ 0"ULY+ 41SE4 ,9 A4I;N1 ,5ID _H R SEV]E KIDNEY 41SE4 ,H] CREAT99E 0 #B.H MG_/D,L 7NORMAL IS #J.H-A.D7 & H] BLOOD UREA NITROG5 7,,BUN7 0 #HC MG_/D,L 7NORMAL IS #G 6#BJ74 ,CREAT99E IS A BYPRODUCT ( NORMAL MUSCLE BR1KD[N & ,,BUN IS A WA/E PRODUCT ( PROTE9 METABOLISM1 F ! BLOOD 96! UR9E4 ,41S$ KIDNEYS ALL[ ^! 6BUILD UP 9 ! BLOOD4 ,NORM,Y1 ,I 4C\RAGE PATI5TS ) SEV]E KIDNEY DYSFUNC;N F -+ 6! CL9IC & REF] !M 6A NEPHROLOGI/4 ,B ? PATI5T 0 DET]M9$ .PP#D 6"UGO TR1T;T AT ! CL9IC1 S ,I MADE AN EXCEP;N4 ,& 9 H] CASE1 X PD (F 9 SPADES4 ,WE />T$ ,5ID ON A !RAPEUTIC DIET1 SPECIFIC NUTRI5TS1 & O!R ALT]NATIVE !RAPIES 6A4RESS H] MULTITUDE ( #AH 3C]NS4 ,%E AL "UW5T A C\RSE ( ,,EECP4 ,AT ! 5D ( H] F\R-WEEK /AY1 %E 0 (F ?REE-F\R?S ( H] DRUGS & ON REDUC$ DOSES ( MO/ (! O!RS4 ,%E _H LO/ #BE P.DS1 ! S5S,N _H RETURN$ 6H] FEET1 & H] BLOOD SUG> 0 9 ! NORMAL RANGE4 ,MO/ REM>KA#1 ,5ID'S CREAT99E & ,,BUN LEVELS _H FALL5 96! NORMAL & NE>-NORMAL RANGES1 #A.B & #BF MG_/D,L1 RESPECTIVELY4 ,9 H] ^WS1 8,6G F NE> FAILURE 6NORMAL 9 F\R WEEKS IS "S?+ NEPHROLOGI/S SAY C'T 2 D"O4 ,B X WAS4 ,?ANK Y = GIV+ ME BACK MY LIFE40 ,9SUL9 & ,OBES;Y3 ,! ,VICI\S ,CYCLE ,:Y D OBES;Y & DIABETES M>* 9 LOCK/EP8 ,Z ,I TOLD Y E>LI] 9 ? REPORT1 TYPE #B DIABETES IS CAUS$ 09SUL9 RESI/.E4 ,& 9 P ) ? 3DI;N1 ! 2TA CELLS 9 ! PANCR1S MAKE PL5TY ( 9SUL91 B ! CELLS >E UNRESPONSIVE 69SUL9'S AC;NS4 ,? L1DS 6A RISE 9 BLOOD SUG>4 ,! PANCR1S RESPONDS 0*URN+ \ M 9SUL91 &! NET RESULT IS ELEVAT$ LEVELS ( BO? GLUCOSE & 9SUL94 ,OBES;Y ?R[S FUEL ON ! FIRE4 #AI ,ADIPOSE TISSUE 7FAT71 ESPECI,Y 9 ! ABDOM9AL >EA1 REL1SES FATTY ACIDS T IMPAIR 2TA-CELL FUNC;N & 9SUL9 S5SITIV;Y4 ,X AL PRODUCES IMMUNE CELLS T L1D 6*RONIC1 L[-GRADE 9FLAMM,N4 ,9FLAMM,N1 9 TURN1 9CR1SES 9SUL9 RESI/.E & RISK ( DIABETES4 ,FAT CELLS AL SECRETE HORM"OS--S _M1 9 FACT1 T "S EXP]TS ACTU,Y REF] 6ADIPOSE TISSUE Z AN 5DOCR9E ORGAN4 ,"O ( ^! HORM"OS IS LEPT94 ,AL? LEPT9 IS BE/ "KN = XS GOV]N+ E6ECTS ON APPETITE & 5]GY METABOLISM1 RESE>*]S F ,BO/ON'S ,JOSL9 ,DIABETES ,C5T] REC5TLY 4COV]$ T X AL HAS DIRECT E6ECTS ON 9SUL9 SECRE;N & 2TA-CELL GR[?4 ,AT ! SAME "T1 ! HI< LEVELS ( 9SUL9 T >E "*I/IC ( TYPE #B DIABETES PROMOTE WEIY FAT-/ORAGE HORM"O--X U%]S FAT Z WELL Z GLUCOSE 96! CELLS4 ,S ! HI<] YR 9SUL9 LEVEL1 ! GRT] YR POT5TIAL WEILY1 EAT+ A H1L?;L DIET1 & TAK+ T>GET$ #BJ NUTRI;NAL SUPPLE;TS4 ,DIABETES & ,,NAFLD ,3TR>Y 6POPUL> 2LIEF1 ! L1D+ LIV] PRO#M 9 ? C.TRY IS N ALCOHOLIC CIRRHOSIS OR HEPATITIS1 B NONALCOHOLIC FATTY LIV] 41SE 7,,NAFLD74 ,A6LICT+ R\E A6ECT$ 0? 3DI;N1 Z >E UP 6?REE-QU>T]S ( OBESE P & #IJ P]C5T (! MORBIDLY OBESE4 ,AL? ,,NAFLD USU,Y DEVELOPS 9 P OV] AGE #EJ1 X IS 2COM+ 9CR1S+LY -MON 9 *N Z OBES;Y RATES SKYROCKET 9 \R "Y] AGE GR\PS4 ,,NAFLD IS A PROGRESSIVE 41SE ) ?REE 4T9CT /AGES4 ,SIMPLE FATTY LIV]1 OR /1TOSIS1 IS "*IZ$ 0ELEV,NS 9 LIV] 5ZYMES & FATLY DEPOSITS 9 ! LIV] 7AT L1/ #AJ P]C5T (! LIV] CELLS >E REPLAC$ 0FAT74 ,IF ! 41SE IS >RE/$ 9 ? /AGE1 X REMA9S RELATIVELY 2NIGN4 ,UN=TUNATELY1 = "O 9 FIVE PATI5TS1 X PROGRESSES #BA 6NONALCOHOLIC /1TOHEPATITIS1 9VOLV+ 9FLAMM,N (! LIV]4 ,F "!1 HALF DEVELOP CIRRHOSIS1 M>K$ 0ADV.ED & IRREV]SI# SC>R+1 FIBROSIS1 & LOSS ( LIV] FUNC;N4 ,! MO/ SIGNIFICANT RISK FACTORS = PROGRES.N 9CLUDE TYPE #B DIABETES & METABOLIC SYNDROME4 ,& Z 4CUSS$ E>LI]1 ! UNIFY+ L9K "H1 -MON ) BO? ( ^! 4ORD]S1 IS 9SUL9 RESI/.E4 ,:5 ! CELLS RESI/ 9SUL9'S SIGNALS 6LET GLUCOSE IN1 ! PANCR1S SECRETES HI<] & HI<] LEVELS ( 9SUL9 6GET ! JOB D"O4 ,ELEVAT$ 3C5TR,NS ( 9SUL9 9 ! BLOOD CR1TE METABOLIC IMBAL.ES T DRIVE UP BLOOD LEVELS ( FREE FATTY ACIDS4 ,? 9FLUX ( FATTY ACIDS OV]:ELMS ! LIV]'S ABIL;Y 6H&LE !M1 & !Y >E 3V]T$ 96TRIGLYC]IDES & /OR$ 9 ! ORGAN1 SETT+ UP A VICI\S CYCLE ( LIPID P]OXID,N 7FREE-RADICAL DAMAGE71 9FLAMM,N1 & LIV] CELL 9JURY4 ,GIVE ,YR ,LIV] ,"S ,,TLC ,! BE/ TR1T;T = PREV5T+ & TR1T+ ,,NAFLD IS WEIE AL HELP;L4 ,! BE/-/UDI$ ANTIOXIDANT = FATTY LIV] IS VITAM9 ;,E1 ) DOSES RANG+ F #DJJ 6#A1BJJ ,,IU P] "D RESULT+ 9 REDUC;NS 9 FATTY LIV] 9FILTR,N4 ,9 A4I;N 6!RAPIES T SPECIFIC,Y A4RESS ,,NAFLD1 "! >E O!R ?+S Y C D 65H.E ! H1L? ( YR LIV]4 ,"O IS 6AVOID "KN LIV] .PP#E TOX9S4 ,G EASY ON ALCOHOL1 ESPECI,Y IF Y'RE OBESE--! -B9,N ( EXCESS ALCOHOL & OBES;Y IS ESPECI,Y DAMAG+ 6! LIV]4 ,Y C AL SUPPORT YR LIV] 0SUPPLE;T+ ) NUTRI5TS T 5H.E LIV] FUNC;N4 ,YR LIV] IS A MAJOR ORGAN ( DETOXIFIC,N1 B R ?AN PHYSIC,Y SCRE5+ \ TOX9S Z _M P 2LIEVE1 X 3V]TS !M 96-P.DS T C 2 ELIM9AT$ F ! BODY4 ,X A3OMPLI%ES ? "? A -PLEX TWO-"P PROCESS CALL$ PHASE ,I & PHASE ,,II DETOXIFIC,N4 #BC ,DUR+ PHASE ,I1 5ZYMES COLLECTIVELY "KN Z CYTO*ROME ,P#DEJ NEUTRALIZE "S TOX9S & R1DY O!RS = PHASE ,,II4 ,PHASE ,,II 9VOLVES A NUMB] ( 3JUG,N REAC;NS T TRANS=M TOX9S 96SAFE1 WAT]-SOLU# -P.DS T C 2 EXCRET$ 9 ! UR9E & BILE4 ,A NUMB] ( NUTRI5TS >E REQUIR$ = EA* ( ^! PHASES4 ,N ! L1/ ( ^! >E ANTIOXIDANTS S* Z LIPOIC ACID1 SILYM>9 7F MILK ?I/LE71 & SEL5IUM 6PROTECT ! LIV] AG/ ! FREE RADICALS G5]AT$ DUR+ PHASE ,I4 ,CALCIUM- ;D-GLUC>ATE1 ;N-ACETYL-CY/E9E1 ELLAGIC ACID 7F.D 9 POMEGRANATES & RASPB]RIES71 & TRIME?YLGLYC9E ALL SUPPORT V>I\S 3JUG,N REAC;NS T O3UR 9 PHASE ,,II DETOXIFIC,N4 ,= G5]AL LIV] SUPPORT1 LOOK =A -B9,N =MULA 9 YR H1L? FOOD /ORE 3TA9+3 #AJJ MG LIPOIC ACID1 #EBF MG SILYM>91 #GJ MCG SEL5IUM1 #BJJ MG CALCIUM-;D-GLUC>ATE1 #FJJ MG ;N-ACETYL-CY/E9E1 #EJ MG ELLAGIC ACID1 & #CJJ MG TRIME?YLGLYC9E4 ,:5 ,Y ,NE$ ,EXTRA ,HELP #BD ,IF Y'VE BE5 DIAGNOS$ ) M ADV.ED LIV] 41SE1 DON'T DESPAIR4 ,UNLIKE O!R ORGANS1 ! DAMAG$ LIV] HAS ! UNIQUE ABIL;Y 6REG5]ATE XF1 PROVID$ T X GETS A LL HELP4 ,WE'VE _H A LOT ( SU3ESS AT ! CL9IC HELP+ P ) 8TRIPLE !RAPY10 DEVELOP$ 0MY FR & COLL1GUE ,BURTON ,B]KSON1 ,,MD1 ,PH,D1 :O PRACTICES M$IC9E 9 ,LAS ,CRUCES1 ,NEW ,MEXICO4 ,? POT5T -BO ( LIPOIC ACID1 SILYM>91 & SEL5IUM DRAMATIC,Y 9CR1SES ! LIV]'S ANTIOXIDANT DEF5SES1 & /IMULATES ! PRODUC;N ( NEW LIV] CELLS4 8,TRIPLE !RAPY0 3SI/S ( #FJJ MG LIPOIC ACID1 #IJJ MG SILYM>91 & #DJJ MCG SEL5IUM4 ,ALL ( ^! NUTRI5TS >E SAFE1 WELL TOL]AT$1 & MAY 2 TAK5 DAILY4 ,TR1T+ ,DIABETES ! ,3V5;NAL ,WAY ,IF Y >E DIAGNOS$ ) TYPE #A DIABETES1 Y'LL IMMLY--& UNAVOIDABLY--BE PRESCRIB$ 9SUL94 ,IF ! DIAGNOSIS IS TYPE #B DIABETES1 Y'LL PROBABLY 2 TOLD 6MAKE "S *ANGES 9 YR DIET & 62G9 EX]CIS+4 #BE ,2Y T1 IF X'S A 3V5;NAL PHYSICIAN1 ,I GU>ANTEE T A DRUG W AL 2 DANGL$ 9 FRONT ( Y1 IF N 62G9 AT ONCE1 !N 6/>T IF YR BLOOD GLUCOSE DOESN'T NORMALIZE ) LIFE/YLE M1SURES4 ,PRESCRIB+ DRUGS IS :AT PHYSICIANS D4 ,M$ICAL S*OOL $UC,N IS L>GELY AN EX]CISE 9 LE>N+ :AT DRUGS 6PRESCRIBE = : 3DI;NS4 ,/UDIES PUBLI%$ 9 ! MO/ PRE/IGI\S M$ICAL J\RNALS R\T9ELY -P>E ! B5EFITS ( "O DRUG 6ANO!R4 ,PRESCRIP;N M$S >E SIMPLY ! HE>T & S\L ( MOD]N M$IC9E4 ,AL? ^! M$IC,NS MAY 2 E6ECTIVE 9 L[]+ BLOOD SUG>1 EA* & E "O ( !M HAS XS PRICE4 ,MO/ ORAL HYPOGLYCEMIC 7BLOOD- GLUCOSE-L[]+7 AG5TS >E NO M ?AN A ,B&- ,AID APPROA* 6DIABETES--!Y L[] BLOOD SUG> B D NO?+ 6A4RESS ! "ULY+ 3DI;N4 ,= EXAMPLE1 ! MAJOR;Y ( DRUGS 9 ? CLASS 9CR1SE 9SUL9 PRODUC;N1 :1 Z ,I H EXPLA9$1 IS N :AT'S NE$$ 9 TYPE #B DIABETES ": FOLKS >E N 9SUL9 DEFICI5T1 B >E 9SUL9 RESI/ANT4 ,O!R TYPES ( DRUGS A6ECT ! WAY C>BOHYDRATES >E METABOLIZ$ 9 ! 9TE/9AL TRACT4 ,"S M$IC,NS #BF ATTEMPT 6IMPROVE 9SUL9 S5SITIV;Y1 H["E1 _! SIDE E6ECTS 79CLUD+ LIV] FAILURE & D1?7 MAKE !M HILY ! CASE ) 3V5;NAL PHYSICIANS & PH>MACEUTICAL -PANIES :5 X -ES 6TR1T+ TYPE #B DIABETES4 ,DOCTORS >E QK 6:IP \ ! PRESCRIP;N PAD1 B ^! S-CALL$ CURES1 ) _! MULTIPLE SIDE E6ECTS1 >E (T5 F> M DAMAG+ ?AN ! 41SE XF4 ,= YE>S DOCTORS H "KN ! POT5TIAL DANG]S ( ORAL HYPOGLYCEMIC DRUGS4 ,B = :AT"E R1SON !Y 3T9UE 6PRESCRIBE !M 6PATI5TS4 ,S MY "Q IS ?3 ,:5 >E WE GO+ 6LE>N--R1 :5 >E WE GO+ 6A3EPT--T ORAL M$IC,NS = TYPE #B DIABETES ACTU,Y D M H>M ?AN GD8 .,W>N+3 ,IF Y >E CURR5TLY TAK+ AN ORAL HYPOGLYCEMIC DRUG1 DON'T /OP TAK+ X4 ,Y M/ "W ) YR DOCTOR 6GRADU,Y #BG 4CONT9UE ! M$IC,N4 ,9 ,FEBRU>Y #BJJH1 RESE>*]S H1D+ A L>GE1 GOV]N;T-FUND$ TRIAL MADE A SOB]+ ANN\NCE;T4 ,! /UDY 9 "Q1 ,AC;N 6,3TROL ,C>DIOVASCUL> ,RISK 9 ,DIABETES 7,,A3ORD71 0 DESIGN$ 6EVALUATE ! E6ECTIVE;S ( V>I\S M$IC,N REGIM5S 9 REDUC+ HE>T ATTACKS1 /ROKES1 & D1? F C>DIOVASCUL> 41SE 9 PATI5TS ) TYPE #B DIABETES4 .PP#F ,"O >M (! /UDY TE/$ ! WIDELY HELD ASSUMP;N T M A7RESSIVE L[]+ ( BLOOD SUG> WD PROVIDE GRT] PROTEC;N AG/ HE>T 41SE4 ,9/1D1 ,,A3ORD F.D J ! OPPOSITE4 ,/UDY "PICIPANTS ON ! MO/ 9T5SIVE DRUG REGIM5S AIM$ AT DRIV+ BLOOD SUG> WAY D[N _H A M* HI<] C>DIOVASCUL> D1? RATE4 8,9T5SIVE BLOOD SUG> L[]+ TR1T;T0 PROV$ 6BE S H>M;L T ! RESE>*]S HALT$ ? >M (! /UDY #AH MON?S E>LY 6PREV5T ? A7RESSIVE DRUG USE F KILL+ EV5 M P4 ,M$ICAL EXP]TS 7 REPORT$LY 8%OCK$10 8/UNN$10 & 8/>TL$0 0? 8UNEXPECT$0 F9D+4 ,FOLKS1 ? IS NONS5SE4 ,WE'VE "KN AB ! FATAL -PLIC,NS ( DIABETES DRUGS #BH S9CE #AIFI1 :5 RESULTS (A SIMIL> /UDY CALL$ ! ,UNIV]S;Y ,GR\P ,DIABETES ,PROGRAM 7 MADE PUBLIC4 ,! GOAL ( ? PLACEBO-3TROLL$ /UDY ( PATI5TS ) TYPE #B DIABETES 0 6SEE IF EI ( TWO ORAL DIABETES DRUGS L[]$ ! 9CID;E ( HE>T ATTACKS & O!R C>DIOVASCUL> -PLIC,NS4 ,9CR$IBLY1 J L ,,A3ORD1 ! /UDY _H 6BE /OPP$ TWO YE>S E>LY 2C "PICIPANTS :O 7 TAK+ ! DRUGS _H A #BEJ 6#CJJ P]C5T HI<] D1? RATE ?AN ^? TAK+ ! PLACEBO4 ,T'S "R3 ,P TAK+ DUMMY PILLS DID F> BETT] ?AN ^? TAK+ DIABETES DRUGS6 ,! ,MA9 ,CULPRITS ,"O (! TWO DRUGS US$ 9 ! OLD] /UDY1 ,,DBI 7PH5=M971 0 %[N 6BE S D1DLY T X 0 TAK5 (F ! M>KET4 ,YET ? DRUG'S CLOSE C\S91 MET=M9 7,GLUCOPHAGE71 : HAS A NE>- ID5TICAL ME*ANISM ( AC;N1 IS ! MO/ POPUL> DIABETES M$IC,N US$ 9 ! ,,US TD & 0 ! MO/ FREQU5TLY US$ DRUG 9 ! ,,A3ORD /UDY4 ,! O!R DRUG US$ 9 ! #AIFI /UDY1 #BI ,OR9ASE 7TOLBUTAMIDE71 0 ULTIMATELY TATTOO$ )A BLACKBOX W>N+ /AT+ T X DRAMATIC,Y 9CR1SES ! WOR/ -PLIC,N ( DIABETES3 D1? F HE>T ATTACK4 ,OR9ASE 2L;GS 6A CLASS ( DRUGS "KN Z SULFONYLUR1S1 : PROMOTE 9SUL9 REL1SE 9 ! PANCR1S1 & >E AL NOTORI\S = CAUS+ WEI M$IC,NS T >E / 9 USE TD1 &! SAME BLACK- BOX W>N+ HAS APPE>$ ON ALL SULFONYLUR1S S9CE #AIHD1 L;G 2F ! ,,A3ORD TRIAL 2GAN4 ,ANO!R CLASS ( DIABETES DRUGS1 &! SECOND-MO/ WIDELY US$ TYPE ( M$IC,N 0,,A3ORD "PICIPANTS1 0 ?IAZOLID9$IONES 7AL CALL$ GLITAZ"OS71 ! MO/ NOTORI\S ( : IS ,AV&IA4 ,9TRODUC$ 9 #AIII1 GOV]N;T EXP]TS E/IMATE T ,AV&IA MAY H CAUS$ Z _M Z #AJJ1JJJ HE>T ATTACKS6 ,9 FACT1 A META-ANALYSIS ( #DB /UDIES ON ? DRUG 0 RU%$ 96PUBLIC,N 9 ! ,NEW ,5GL& ,J\RNAL ( ,M$IC9E 9 #BJJG 2C X 3CLUD$ T ,AV&IA SIGNIFICANTLY 9CR1S$ C>DIOVASCUL> RISK4 ,&A M REC5T ,CANADIAN /UDY REV1LS T1 -P>$ 6O!R DIABETES DRUGS1 ,AV&IA 9CR1SES RISK ( HE>T FAILURE 0#FJ P]C5T1 #CJ HE>T ATTACK 0#DJ P]C5T1 & D1? 9 PATI5TS AGE #FE & OV] 0#CJ P]C5T4 ,) SIDE E6ECTS L ^!1 X'S NO WOND] T 9T5SIVE DRUG USE 9 ! ,,A3ORD /UDY CAUS$ S _M D1?S4 ,! ONLY 8%OCK+0 ?+ IS T PHYSICIANS P]SI/ 9 US+ ^! DANG]\S DRUGS AT ALL6 ,>E WE RE,Y GO+ 6LET ANO!R ?REE DECADES G 02F WE TAKE ? JUNK (F ! M>KET8 ,Y ,%D ,2 ,AL>M$ ,! FALL\T F ,,A3ORD HAS BE5 PREDICTA#4 ,9 AN EF=T 6ALLAY 3C]NS1 /UDY ORGANIZ]S ASS]T1 8,PATI5TS ) TYPE #B DIABETES %D N 2 AL>M$ 0^! F9D+S (! ,,A3ORD TRIAL40 ,YES1 !Y %D 2 AL>M$6 ,! ,UNIV]S;Y ,GR\P ,DIABETES ,PROGRAM /UDY 4CUSS$ E>LI] -P>$ DRUGS 6A PLACEBO1 PROV+ T ! DRUGS !MVS CAUS$ H>M--A TWO-&-A-HALF 6?REEFOLD 9CR1SE 9 D1?S F C>DIOVASCUL> 41SE6 ,Y MAY 2 ?9K+1 :AT AB ! O!R -PLIC,NS ( DIABETES8 ,SURELY ^! DRUGS (F] "S PROTEC;N4 ,AC 6,NORT9 ,_HL]1 ,,MD1 (! ,UNIV]S;Y ( ,NOR? ,C>OL9A AT #CA ,*APEL ,HILL1 Z QUOT$ 9 ,BUSI;S,WEEK1 NO ORAL DIABETES DRUG 8HAS "E BE5 %[N 6D ANY?+ RE,Y GD = ANY PATI5T4 ,NO LEG1 EYE1 KIDNEY1 HE>T1 OR BRA9 HAS "E BE5 SP>$40 ,9 MY OP9ION1 Y'D 2 BETT] (F ) NO PROGRAM AT ALL ?AN ) ^! DRUGS4 ,UNLIKE TYPE #A DIABETES1 TYPE #B IS N 9H]5TLY FATAL4 ,X J M1NS Y'RE WALK+ >.D ) AN ABV-AV]AGE LEVEL ( BLOOD SUG>4 ,:Y ,IS ! ,NATURAL ,APPROA* ,IGNOR$8 ,NUM]\S SCI5TIFIC /UDIES SUPPORT TAK+ A SAFE1 NATURAL APPROA* 6TR1T+ DIABETES4 ,YET ! VA/ MAJOR;Y ( PHYSICIANS 3T9UE 6IGNORE ! RESE>*--& JEOP>DIZE ! H1L? ( TRU/+ PATI5TS--0FOCUS+ /RICTLY ON L[]+ BLOOD SUG>1 NO MATT] :AT ! CO/4 .PP#G ,"P (! PRO#M C 2 LAID AT ! FEET ( HUMAN PSY*OLOGY4 ,:5 A DOCTOR SEES A PATI5T ) TYPE #B DIABETES1 HE MAY GIVE LIP S]VICE 6DIET & EX]CISE4 ,B 6BE RE,Y E6ECTIVE1 HE M/ 2COME A C\NSELOR :O 5C\RAGES & MONITORS 8 PATI5T'S #CB ACTIV;Y LEVEL1 DIET1 & WEIGES 8 RESPONSIBIL;Y4 ,& PATI5TS A3EPT ? 2C X'S AN EASY \ = !M Z WELL4 ,:AT CD 2 SIMPL] ?AN TAK+ A 8MAGIC PILL10 ESPECI,Y IF ADV]SE SIDE E6ECTS >E GLOSS$ OV]1 Z !Y USU,Y >E8 ,! PH>MACEUTICAL 9DU/RY AL %\LD]S M* (! BLAME4 ,^! -PANIES CURR5TLY 3TROL ! BULK ( M$ICAL RESE>*1 TR1T;T GUIDEL9ES1 & PHYSICIAN 8$UC,N40 ,Z A RESULT1 N ONLY IS ! E6ECTIVE;S ( DRUGS OV]/AT$ &! RISKS M9IMIZ$1 B ! EMPHASIS ON M$IC,N DRAWS ATT5;N AWAY F SAFE1 NATURAL !RAPIES T TRULY IMPROVE ! H1L? & L;GEV;Y ( P ) DIABETES4 ,PREV5T+ & ,TR1T+ ,DIABETES ! ,NATURAL ,WAY ,Z ,I H SD 2F1 TYPE #B DIABETES IS PRIM>ILY A RESULT (A POOR #CC LIFE/YLE4 ,9 MO/ CASES1 A FEW ADJU/;TS 9 H[ Y G AB YR DAILY LIFE C L[] YR RISK ( DEVELOP+ TYPE #B DIABETES4 ,&1 ! RECOMM5D,NS ,I AM AB 6DESCRIBE >E "S (! SAME !RAPIES ,I USE = TR1T+ P :O ALR H DIABETES4 ,B1 ( C\RSE1 X'S ALW BETT] 6PREV5T 41SE ?AN TR1T X4 ,PREV5;N C SAVE Y M"OY1 B M IMPORTANT1 X C SAVE YR LIFE4 ,WAT* ,YR ,DIET ,:AT Y EAT HAS A PROF.D E6ECT ON YR BLOOD GLUCOSE LEVELS4 ,9 FACT1 "O (! PRIM>Y R1SONS _M P H 6MONITOR _! LEVELS S CLOSELY ^! "DS IS 2C M & M EM]G+ N,NS >E ADOPT+ ! ,WE/]N DIET T WE'VE 85JOY$0 = YE>S4 ,9DIG5\S DIETS ( FRE% FRUITS1 VEGETA#S1 & LEGUMES >E 2+ REPLAC$ ) PROCESS$1 REF9$ FOODS T H BE5 /RIPP$ ( _! NATURAL FIB]S & NUTRI5TS4 ,M1T HAS 2COME M PROM95T 9 ! DAILY DIET1 & FA/- FOOD RE/AURANTS >E SPR++ UP ALL OV] ! GLOBE4 ,=TUNATELY1 0REV]T+ BACK 6A M #CD 8PRIMITIVE0 DIET1 Y C EASILY-& NATUR,Y-- PROMOTE & MA9TA9 H1L?Y BLOOD SUG> LEVELS4 ,LET ! ,GLYCEMIC ,LOAD ,2 ,YR ,GUIDE ,! F/ ?+ Y %D D IF Y WANT 6SUPPORT H1L?Y BLOOD SUG> LEVELS IS 2COME AW>E ( H[ QKLY YR BODY BR1KS D[N C]TA9 FOODS 96GLUCOSE4 ,"O WAY 6D ? IS )! GLYCEMIC 9DEX 7,,GI74 ,FOODS )A HI< ,,GI1 S* Z REF9$ C>BOHYDRATES & SUG>S1 >E RAPIDLY BROK5 D[N 96GLUCOSE1 DRIV+ UP BLOOD SUG> LEVELS & PLAC+ AN 9CR1S$ BURD5 ON NORMAL METABOLIC PROCESSES4 ,FUEL+ YR BODY ) ^! QK-BURN+ C>BOHYDRATES C AL L1VE Y FEEL+ TIR$1 HUNGRY1 & IRRITA#4 ,ON ! O!R H&1 VEGETA#S1 LEGUMES1 & "S FRUITS CAUSE A SL[1 SU/A9$ REL1SE ( GLUCOSE 96! BLOOD/R1M4 ,!Y'LL KEEP YR 9SUL9 F SPIK+1 PROVIDE A SU/A9$ S\RCE ( 5]GY1 & SATISFY YR HUNG] OV] ! L;G HAUL4 ,C\PLE ^! SL[ BURN]S ) MOD]ATE AM.TS ( L1N PROTE9 & H1L?Y MONOUNSATURAT$ & POLYUNSATURAT$ FATS S* Z ^? F.D 9 #CE NUTS1 SE$S1 & EXTRA-VIRG9 OLIVE OIL1 & Y'RE ON YR WAY 6BETT] BLOOD SUG> 3TROL4 ,ANO!R WAY 6DET]M9E H[ A FOOD MAY A6ECT YR BLOOD SUG> IS 0LOOK+ AT XS GLYCEMIC LOAD 7,,GL74 ,BAS$ ON ! SAME 3CEPT Z ! ,,GI1 B A LL M PRACTICAL1 ,,GL TAKES 96A3.T QUAL;Y & QUANT;Y4 ,X IS DET]M9$ 0BO? ! ,,GI ( ANY GIV5 FOOD1 PLUS ! AM.T ( AVAILA#1 OR NET1 C>BOHYDRATES 7FIB] EXCLUD$7 9 A /&>D S]V+4 ,! ,,GL HAS REV1L$ A FEW SURPRISES3 ,"S FOODS )A HI< ,,GI ACTU,Y H M9IMAL E6ECTS ON BLOOD SUG> LEVELS :5 EAT5 9 NORMAL QUANTITIES1 :ILE O!RS )A L[ ,,GI >E POT5TI,Y PRO#MATIC4 ,= EXAMPLE1 A L>GE C>ROT &A CUP ( SPA ,,GI,'S4 ,YET T C>ROT 3TA9S ONLY #E GRAMS ( AVAILA# C>BS 7X'S MO/LY WAT]71 :ILE ! SPA4 ,C>ROTS1 WAT]MELON1 P9EAPPLE1 & O!R FRUITS )A HI< ,,GI ONCE ?"\ 6BE 9APPROPRIATE = ^? M9D+ _! #CF GLUCOSE LEVELS TURN \ 6BE A3EPTA#1 :ILE ! ,,GL 3FIRMS ! NE$ 6CUT \ PA/A1 BAGELS1 & O!R />*Y1 C>BOHYDRATE-D5SE FOODS4 ,HUNDR$S ( /UDIES ON ! E6ECTS (A L[ ,,GI OR ,,GL DIET H BE5 3DUCT$1 MO/ ( !M FOCUS$ ON BLOOD SUG>4 ,"O TYPICAL /UDY1 A META-ANALYSIS ( CL9ICAL TRIALS 9VOLV+ M ?AN #CEJ PATI5TS1 REV1L$ T A L[ ,,GL DIET IMPROV$ BO? L;G- & %ORT-T]M MANAGE;T ( BLOOD SUG> LEVELS4 ,6QKLY LITY SALAD )A NICE PIECE ( SALMON ON TOP4 ,X'S AN EASY WAY 6GET A TA/Y S]V+ ( H1L?Y FATS1 PL5TY ( PROTE91 & LOTS ( L[ ,,GL C>BS4 ,GLYCEMIC ,9DEX -- ,GLYCEMIC ,LOAD ,L[ #EE OR "U -- #AJ OR "U ,M$IUM #EF-FI -- #AA-AI ,HI< #GJ OR ABV -- #BJ OR ABV ,= M AB ,,GI_/,,GL &A LI/ ( #CG GLYCEMIC 9DEXES & GLYCEMIC LOADS = -MON FOODS1 VISIT MENDOSA.COM/GILISTS.HTM ,NIX ,SATURAT$ & ,TRANS ,FATS ,EXCESS FAT1 "PICUL>LY SATURAT$ FATS F M1T & :OLE DAIRY PRODUCTS & TRANS FATS F.D 9 PROCESS$ & MO/ FA/ FOODS1 C WR1K HAVOC ON YR BODY4 ,Z E>LY Z ! #AIBJ'S X 0 DEMON/RAT$ T A HI<-SATURAT$-FAT DIET N ONLY CAUSES WEI 3TROL 9 P ) DIABETES4 ,S1 IF Y WANT 6MA9TA9 A H1L?Y WEI LEVEL1 ,I RECOMM5D ELIM9AT+ ^! FOODS F YR DIET4 ,AVOID ,/>*ES & ,SUG>S ,9 A FUTILE EF=T 6LOSE WEIBOHYDRATES ) HI< ,,GI,'S4 7,REMEMB]1 FOODS )A HI< #CH ,,GI >E BROK5 D[N QKLY 96SUG>S1 : L1DS 6RAPID SPIKES 9 BLOOD SUG> LEVELS47 ,WE'VE AL 2COME SUG> JUNKIES4 ,AC 6,,US ,DE"P;T ( ,AGRICULTURE /ATI/ICS1 ,AM]ICANS 3SUME AN AV]AGE ( #ADI P.DS ( SWEET5]S A YE>--N C.T+ ! >TIFICIAL SWEET5]S S* Z ASP>TAME 7,NUTRA,SWEET & ,EQUAL7 T WE 3SUME 9 OV] #G1JJJ PRODUCTS4 ,DUE 6! NEGATIVE E6ECTS FAT-FREE FOODS1 SUG>S 79CLUD+ HI<-FRUCTOSE CORN SYRUP71 & >TIFICIAL SWEET5]S C H ON YR BLOOD SUG>--& YR OV]ALL H1L?--X IS BE/ IF Y AVOID !M Z M* Z POSSI#4 ,T 2+ SD1 ,I "K Z WELL Z Y T CRAV+S = SWEET TR1TS >5'T GO+ 64APPE>4 ,=TUNATELY1 "! >E H1L?Y ALT]NATIVES4 ,"O IS D>K *OCOLATE1 : ,I'LL TELL Y M AB 9 A MO;T4 ,"! >E AL A FEW NATURAL SWEET5]S Y C USE 9 PLACE ( SUG>4 ,SEE ! H1D+ ON BRL PAGE .#DC =! "OS ,I RECOMM5D4 ,GRT ,NEWS = ,*OCOLATE ,LOV]S #CI ,SCI5TI/S H 4COV]$ T COCOA LIQUOR1 ! CR1MY PA/E ( GR.D1 ROA/$ CACAO B1NS US$ 6MAKE *OCOLATE1 IS NATURE'S RI*E/ S\RCE ( POLYPH5OLS1 A CLASS ( PHYTONUTRI5TS ) POT5T ANTIOXIDANT ACTIV;Y & O!R !RAPEUTIC E6ECTS4 ,N[1 ,I "K _M ( Y >E ?9K+ T SUG> LAD5 *OCOLATE IS ! LA/ ?+ P ) DIABETES %D 2 EAT+4 ,B1 :ILE X'S TRUE *OCOLATE HAS FAT & CALORIES--& X TA/ES WAY TOO GD 6BE GD = Y--! H1L? B5EFITS ( D>K *OCOLATE _C 2 D5I$4 ,SURPRIS+LY1 ,ITALIAN RESE>*]S 4COV]$ T D>K *OCOLATE SIGNIFICANTLY IMPROV$ M>K]S ( 9SUL9 S5SITIV;Y1 DECR1S+ FA/+ 9SUL9 & GLUCOSE LEVELS1 Z WELL Z 9SUL9 & GLUCOSE RESPONSES 6! GLUCOSE TOL].E TE/4 ,HI<-QUAL;Y D>K *OCOLATE IS SOLD 9 H1L? FOOD1 SPECIALTY1 & GROC]Y /ORES4 ,LOOK = B>S T 3TA9 #GJ P]C5T COCOA OR M4 ,DON'T 2 PUT (F 0! FAT 3T5T1 & EXPECT X 6H "S SUG>4 ,UNSWEET5$ D>K *OCOLATE IS EXTREMELY BITT] &1 EV5 SWEET5$1 X IS AN ACQUIR$ TA/E = "S1 S %OP >.D =A #DJ BR& Y L4 ,& EAT X 9 MOD],N4 ,A SQU>E OR TWO ( D>K *OCOLATE E O!R "D OR S IS 5 6SATISFY YR SWEET TOO?4 ,6KEEP CALORIC 9TAKE /1DY1 EAT X 9 PLACE (1 R ?AN 9 A4I;N TO1 O!R FOODS OR SNACKS4 ,SPICE X ,UP6 ,C9NAMON 3TA9S AN 9GR$I5T CALL$ ME?YLHYDROXY*ALC"O POLYM] 7,,MHCP7 :1 9 A4I;N 62+ A POT5T ANTIOXIDANT1 AL IMPROVES 9SUL9 S5SITIV;Y4 ,H["E1 RESE>* SU7E/S T *EMICALS 9 SALIVA R5D] X 9E6ECTIVE1 S ,I DON'T RECOMM5D J A4+ GR.D C9NAMON 6YR FOOD4 ,TAKE A WAT]SOLU# C9NAMON EXTRACT 9/1D4 ,Y %D 2 A# 6F9D MULTIPLE BR&S 9 YR LOCAL H1L? FOOD /ORE4 ,! UNDESIRA# -P.DS T C9NAMON 3TA9S >E ELIM9AT$ :5 MIX$ 9 HOT WAT]4 ,"!=E1 DR9K+ C9NAMON TEA OR A4+ C9NAMON 6GR.D C(FEE 2F BREW+ >E O!R GRT OP;NS4 ,! SU7E/$ DOSE IS A QU>T] 6A HALF T1SPOON 7OR ! SUPPLE;T EQUIVAL5T7 TWICE A "D4 ,! ,P[] ( ,V9EG> #DA ,RESE>*]S :O 7 /UDY+ ! E6ECTS ( V9EG> ON P ) DIABETES F.D T TWO TA#SPOONS ( APPLE CID] V9EG> 7MIX$ ) WAT] &A NON- CALORIC SWEET5]7 REDUC$ GLUCOSE & 9SUL9 RESPONSE :5 TAK5 J 2F A HI<-C>BOHYDRATE M1L 7BAGEL & ORANGE JUICE74 ,V9EG> "W$ J Z WELL Z DIABETES DRUGS1 CUTT+ ! USUAL BLOOD SUG> .PP#I SURGE 9 DIABETICS & ^? ) 9SUL9 RESI/.E 7PRE-DIABETES7 0#BE & #EJ P]C5T1 RESPECTIVELY1 & IMPROV+ 9SUL9 S5SITIV;Y #AI & #CD P]C5T4 ,YET ASIDE F XS PUNG5T TA/E1 V9EG> HAS NO ADV]SE E6ECTS & CO/S ONLY 4#AE 64#BJ A YE>4 ,9 A FOLL[-UP /UDY1 ! L1D RESE>*]1 ,C>OL ,JOHN/ON1 ,PH,D1 9/RUCT$ VOLUNTE]S 6TAKE TWO TA#SPOONS ( V9EG> 2F TWO ( _! DAILY M1LS = F\R WEEKS4 ,DUR+ T "T1 !Y LO/ AN AV]AGE ( TWO P.DS1 & "S LO/ UP 6F\R 7WEI MAY 9T]F]E ) 5ZYMES T BR1K D[N C>BOHYDRATES1 ALL[+ !M 6PASS "? )\T 2+ ABSORB$4 ,TRY ,? ,RELAX+ ,B"EAGE #DB ,NEXT 6WAT]1 TEA IS "O (! H1L?IE/ B"EAGES ON ! PLANET4 ,! CA6E9E & POLYPH5OLS 9 TEA >E !RMOG5IC AG5TS1 M1N+ !Y HELP BOO/ WEI--*AMOMILE & :ITE--APPE> 6HELP L[] BLOOD SUG> Z WELL4 ,JAPANESE SCI5TI/S GAVE A GR\P ( RATS ) DIABETES A *AMOMILE EXTRACT ) _! M1LS E "D = ?REE WEEKS4 ,-P>$ 6A 3TROL GR\P1 ! ANIMALS 3SUM+ *AMOMILE _H 4T9CTLY L[] BLOOD GLUCOSE LEVELS4 ,EQU,Y IMPORTANT1 ? H]BAL EXTRACT SUPPRESS$ 5ZYMES T >E L9K$ 69CR1S$ RISK ( -PLIC,NS -MONLY ASSOCIAT$ ) DIABETES1 S* Z VI.N1 KIDNEY1 & N]VE DAMAGE4 ,GRANT$1 ANIMAL /UDIES >E A F> CRY F HUMAN CL9ICAL TRIALS1 B A4+ A CUP OR TWO ( *AMOMILE TEA 6YR DAILY R\T9E ISN'T A BAD IDEA4 ,TRY DR9K+ X ) OR "R AF M1LS1 Z *AMOMILE HAS AL BE5 %[N 6AID 9 DIGES;N & PREV5T HE>TBURN & FLATUL;E4 ,LESS WELL "KN ?AN XS BLACK & GRE5 C.T]"PS1 :ITE TEA BOA/S _M H1L? #DC B5EFITS--AL;G )A SWEET]1 MILD] TA/E4 ,"O ( MY SUBSCRIB]S %>$ ) ME H[ 9CORPORAT+ :ITE TEA 96YR DIET C HELP L[] BLOOD SUG>4 ,YR >TICLE ON :ITE TEA 9T]E/$ ME1 S ,I B"\ "S F A /ORE 9 ,DETROIT4 ,MY WIFE & ,I F.D T "O OR TWO CUPS A "D DROPP$ \R BLOOD SUG> LEVELS 6! PO9T T ,I 0 A# 6REDUCE MY PRESCRIP;N DRUGS = DIABETES4 ,WE _H TRI$ ALOE V]A JUICE1 *]RY JUICE1 & O!R PRODUCTS1 B !Y SOON FELL 0! WAYSIDE4 ,B ? :ITE TEA RE,Y "WS4 -- ,,RW1 ,PORTAGE1 ,,MI ,SAFE ,SWEET5]S ,0F>1 MY FAVORITE SWEET5]S >E ! NATURAL "OS4 ,TOPP+ ! LI/ IS /EVIA4 ,? H]B HAS BE5 US$ = OV] #A1EJJ YE>S 9 ,S\? ,AM]ICA & BOA/S _WWIDE POPUL>;Y4 ,X IS CALORIE-FREE & DOES N A6ECT BLOOD SUG> LEVELS4 ,J A FEW DROPS (A LIQUID 3C5TRATE OR A DU/+ ( P[D]$ /EVIA IS ALL Y NE$ 6L5D SWEET;S 6ANY DI%4 ,X'S ! SWEET5] ( *OICE AT ! ,:ITAK] #DD ,WELL;S ,9/ITUTE1 & IF Y HAV5'T TRI$ X YET1 Y %D4 ,RUNN+ A CLOSE SECOND IS XYLITOL4 ,? SWEET5] LOOKS & TA/ES L SUG>1 MAK+ X ID1L = BAK+4 ,BETT] YET1 X'S GD = YR TEE?3 ,XYLITOL ACTU,Y REDUCES CAV;Y & PLAQUE =M,N1 A D5TAL CLAIM APPROV$ 0! ,,FDA4 ,AL? XYLITOL IS N CALORIE-FREE1 X IS METABOLIZ$ M* M SL[LY ?AN REGUL> SUG> & HAS AN EXTREMELY L[ GLYCEMIC 9DEX4 ,! ONLY REPORT$ SIDE E6ECT IS GA/RO9TE/9AL 4TRESS :5 L>GE AM.TS >E 9GE/$4 ,AL? /EVIA & XYLITOL >E MY TOP *OICES = SWEET5]S1 ,I R1LIZE T !Y >5'T = "EY"O4 ,/EVIA'S AFTA/E C 2 A LL /R;G = "S1 &1 Z ,I M5;N$ ABV1 "S P C EXP]I;E DIGE/IVE 4TRESS ) XYLITOL4 ,=TUNATELY1 ,I REC5TLY 4COV]$ ANO!R SWEET5] T IS AL #AJJ P]C5T NATURAL T TA/ES J L SUG>1 B HAS #GE P]C5T FEW] CALORIES & IS #GJ-HJ P]C5T L[] ON ! GLYCEMIC 9DEX4 ,X IS CALL$ ,:EY ,L[4 ,L XYLITOL1 X IS GRT = BAK+4 ,Y C AL USE ,:EY ,L[ 9 TEA & C(FEE1 & ANY": ELSE Y WD TYPIC,Y USE SUG>4 ,Y C F9D /EVIA & XYLITOL 9 H1L? #DE FOOD /ORES4 ,:EY ,L[ IS AVAILA# 0CALL+ #HHH-HHF-HBAC4 ,E/ABLI% AN ,EX]CISE ,R\T9E ,REGUL> EX]CISE IS V IMPORTANT IF Y WANT 6E6ECTIVELY 3TROL YR BLOOD SUG> LEVELS4 ,EX]CISE AL HELPS NORMALIZE WEI*]S AT ,/AN=D &! ,UNIV]S;Y ( ,CALI=NIA-,B]KELEY :O FOLL[$ ALM #F1JJJ M5 = #AD YE>S DET]M9$ T 9CR1S$ PHYSICAL ACTIV;Y 0 E6ECTIVE 9 PREV5T+ TYPE #B DIABETES4 ,& X 0 ESPECI,Y PROTECTIVE = M5 )! HI & BURNS CALORIES1 :ILE RESI/.E TRA9+1 S* Z WEIE A FEW M ITEMS T H BE5 %[N 6HELP REDUCE APPETITE1 DECR1SE FOOD 9TAKE1 & HELP PROMOTE H1L?Y WEI BAL.E4 99 ,!RMOG5IC AG5TS AID WEII ,DES]T 6/AVE (F HUNG] & ?IR/ DUR+ L;G TREKS1 HOODIA ACTIVATES ! HUNG]_/SATIETY C5T] 9 ! BRA94 ,HOODIA HAS CR1T$ A GD D1L ( BUZZ 9 ! 9DU/RY1 & /UDIES H %[N T X IS HIA?ONS-- J GET ACTIVE4 ,BRISK WALK+ IS "O (! EASIE/ EX]CISES1 ESPECI,Y = 2G9N]S1 & AT ,:ITAK] ,WELL;S1 WE TAKE PATI5TS ON A #AJ-M9UTE WALK AF M1LS 2C ? HELPS CLE> GLUCOSE \ (! BLOOD/R1M4 ,/UDIES H AL %[N T REGUL> EX]CISE RESETS YR BODY'S !RMO/AT = H\RS AF Y /OP EX]CIS+--: IS PRECISELY :AT Y WANT4 ,S ! MO/ IMPORTANT ?+ IS 6*OOSE "S?+ Y 5JOY & /ICK ) X4 ,I RECOMM5D AT L1/ #CJ M9UTES ( AEROBIC EX]CISE MO/ "DS (! WEEK2 & S"EAL SES.NS ( RESI/.E TRA9+ WEEKLY4 ,TAKE ,NUTRI;NAL ,SUPPLE;TS = ,EXTRA ,SUPPORT ,:ILE EAT+ A H1L?;L DIET & EX]CIS+ REGUL>LY >E ESS5TIAL = E6ECTIVE BLOOD SUG> 3TROL1 ,I AL RECOMM5D TAK+ NUTRI;NAL SUPPLE;TS = EXTRA SUPPORT4 ,! KEY 6! TR1T;T ( DIABETES IS #DH TWOFOLD--3TROL ( BLOOD GLUCOSE LEVELS &1 EQU,Y IMPORTANT1 ! PREV5;N ( -PLIC,NS4 ,YET :ILE 3V5;NAL PHYSICIANS D ATTEMPT 6/AVE (F -PLIC,NS 0KEEP+ BLOOD SUG>S 9 ! NORMAL RANGE1 !Y IGNORE ! SOLID SCI5TIFIC RESE>* T SUPPORTS ! A7RESSIVE USE ( SPECIFIC NUTRI;NAL SUPPLE;TS = PROTEC;N AG/ ! RAVAGES ( DIABETES4 ,? IS1 9 MY OP9ION1 "O (! MO/ OBVI\S & 9EXCUSA# BL SPOTS ( 3V5;NAL M$IC9E & X C ONLY 2 EXPLA9$ 0AN IRR,NAL BIAS AG/ NUTRI;NAL SUPPLE;T,N4 ,REPLACE ,LO/ ,VITAM9S & ,M9]ALS ,Z ,I EXPLA9$ E>LI]1 DIABETES IS A NUTRI;N,Y WA/+ 41SE4 ,MASSIVE AM.TS ( NUTRI5TS >E LO/ Z ! KIDNEYS RID ! BODY ( EXCESS GLUCOSE 09CR1S+ UR9,N1 S ! F/ /EP IS REPLACE;T ( ^! LO/ NUTRI5TS4 ,AM;G ! MO/ SIGNIFICANT LOSSES >E ! ;,B-COMPLEX VITAM9S1 & _M P ) DIABETES H SUBOPTIMAL CELLUL> LEVELS ( ^! VITAL NUTRI5TS4 ,VITAM9S ,B#F1 ,B#AB1 & BIOT9 IMPROVE 9SUL9 S5SITIV;Y & AL HELP PREV5T #DI DIABETIC -PLIC,NS1 "PICUL>LY NEUROPA?Y4 ,SUPPLE;T,N IS IMP]ATIVE1 ) RECOMM5D$ DOSES ( #GE MG ( ,B#F1 #AEJ MCG ( ,B#AB1 & #CJJ MCG ( BIOT9 DAILY4 ,ANTIOXIDANTS >E AL IMPORTANT4 ,VITAM9 ;,C1 ! MO/ ACTIVE ANTIOXIDANT 9 \R WAT]- BAS$ TISSUES1 L[]S LEVELS ( SORBITOL1 ! SUG> T COLLECTS 9 & DAMAGES CELLS (! EYES1 KIDNEYS1 OR N]VES4 ,VITAM9 ;,E1 ! BODY'S PREMI] FAT-SOLU# ANTIOXIDANT1 IMPROVES GLUCOSE 3TROL & PROTECTS BLOOD VESSELS & N]VES F FREE-RADICAL DAMAGE1 : IS A3EL]AT$ 0! DIABETIC 3DI;N4 ,/UDIES H %[N T HI< DOSES ( SUPPLE;TAL VITAM9 ;,E MAY EV5 REV]SE DAMAGE 6N]VES CAUS$ 0DIABETES & PROTECT AG/ DIABETIC CAT>ACTS & A!ROSCL]OSIS4 7,= M AB VITAM9 ;,E1 SEE ! H1D+ ON BRL PAGE .#EC47 ,SUPPLE;T,N ) BO? ( ^! ANTIOXIDANTS IS ASSOCIAT$ )A REDUC$ RISK ( DIABETIC RET9OPA?Y4 ,I RECOMM5D AT L1/ #A1JJJ MG ( VITAM9 ;,C & #DJJ-HJJ ,,IU ( NATURAL VITAM9 ;,E DAILY4 7,Y C TELL X'S NATURAL IF X'S LI/$ Z ;D-ALPHA-TOCOPH]OL OR ;D- ALPHA-TOCOPH]YL4 ,SYN!TIC VITAM9 #EJ ;,E IS LI/$ Z D#A-ALPHA2 NOTE ! 8#A407 ,DIABETICS AL T5D 6H L[ LEVELS ( MAGNESIUM1 & ^? )! L[E/ LEVELS >E MO/ LIKELY 6H DIABETIC RET9OPA?Y & O!R EYE PRO#MS4 ,I SU7E/ SUPPLE;T+ ) #EJJ-A1JJJ MG ( MAGNESIUM DAILY4 ,9 MO/ CASES1 Y %D 2 A# 6GET ^! DOSAGES F A HI<-QUAL;Y MULTIVITAM9 & M9]AL SUPPLE;T4 ,IF N1 Y %D ADD 9DIVIDUAL NUTRI5TS 6A*IEVE ! !RAPEUTIC AM.TS RECOMM5D$4 ,VANADIUM3 ,_W'S ,MO/ ,LIFESAV+ ,BLOOD ,SUG> ,SUPPLE;T ,9 MY OP9ION1 "O (! MO/ E6ECTIVE & 9TRIGU+ NUTRI;NAL SUPPLE;TS = MANAG+ BLOOD SUG> LEVELS IS VANADIUM4 ,? UNIQUE TRACE M9]AL1 : IS F.D 9 FOODS S* Z MU%ROOMS .PP#AA & %ELLFI%1 L[]S BLOOD SUG> 0MIMICK+ 9SUL9 & IMPROV+ ! CELLS' S5SITIV;Y 69SUL94 ,/UDIES %[ T SUPPLE;T,N ) VANADIUM 7Z VANADYL SULFATE7 M>K$LY L[]S FA/+ GLUCOSE & IMPROVES O!R M1SURES ( DIABETES4 #EA ,9 "O /UDY1 EI1 : LA/$ WELL 96! PLACEBO P]IOD AF ! M9]AL 0 4CONT9U$4 ,! ONLY REPORT$ ADV]SE E6ECT 0 M9OR GA/RO9TE/9AL 4TRESS DUR+ ! F/ FEW "DS (! /UDY4 ,! SU7E/$ DOSE ( VANADYL SULFATE IS #AJJ-AEJ MG DAILY4 ,*ROMIUM ,IMPROVES ,GLUCOSE ,METABOLISM ,*ROMIUM IS A TRACE M9]AL T IMPROVES ! AC;N ( 9SUL9 & HELPS MOVE GLUCOSE & O!R NUTRI5TS 96! CELLS4 ,XS !RAPEUTIC VALUE 0 F/ 4COV]$ 9 ! #AIEJ;S1 :5 RESE>*]S ISOLAT$ A PREVI\SLY UN"KN SUB/.E F PORK KIDNEY4 ,:5 !Y GAVE ? SUB/.E 6LABORATORY RATS ) GLUCOSE 9TOL].E 7A PRE-DIABETIC =M ( 9SUL9 RESI/.E71 X CAUS$ S* SIGNIFICANT IMPROVE;TS T !Y "ND X GLUCOSE TOL].E FACTOR 7,,GTF74 ,? UNIQUE -P.D 0 F.D 6IMPROVE ! ACTIV;Y ( #EB 9SUL9 & FACILITATE ! UPTAKE ( GLUCOSE 96! CELLS4 ,RESE>* 9T5SIFI$ &1 9 #AIEI1 ! ACTIVE 9GR$I5T 9 ,,GTF 0 ID5TIFI$3 *ROMIUM4 ,*ROMIUM DOESN'T CAUSE ! BODY 6MAKE M 9SUL9--X J HELPS MAKE 9SUL9 "W BETT]4 ,AT L1/ #AE WELL-3TROLL$ CL9ICAL TRIALS T EXAM9$ ! E6ECTS ( SUPPLE;TAL *ROMIUM ON PATI5TS ) DIABETES1 9SUL9 RESI/.E1 & O!R BLOOD SUG> ABNORMALITIES H %[N T ? M9]AL IMPROVES GLUCOSE METABOLISM4 ,9 "O /UDY 3DUCT$ 0! ,,US ,DE"P;T ( ,AGRICULTURE'S ,HUMAN ,NUTRI;N ,RESE>* ,C5T] & ,BEIJ+ ,M$ICAL ,UNIV]S;Y1 #AHJ P ) TYPE #B DIABETES 7 DIVID$ 96?REE GR\PS & GIV5 SUPPLE;TS 3TA9+ #AJJ MCG *ROMIUM PICOL9ATE1 #EJJ MCG *ROMIUM PICOL9ATE1 OR PLACEBO1 TWICE A "D4 ,NO O!R *ANGES 7 MADE 9 _! M$IC,NS1 DIETS1 OR ACTIV;Y LEVELS4 ,:5 _! BLOOD GLUCOSE LEVELS 7 TE/$ AF F\R MON?S1 ! PATI5TS TAK+ *ROMIUM _H REDUC;NS 9 BLOOD SUG>1 9SUL91 *OLE/]OL1 & GLYCAT$ HEMOGLOB9 7A L;G]- T]M M1SURE ( BLOOD SUG> 3TROL74 ,*ROMIUM HAS AL BE5 DEMON/RAT$ #EC 6FACILITATE WEI* SU7E/S T APPROXIMATELY #DJ P]C5T ( P ) DIABETES H A G5E V>I,N 7HAPTOGLOB9 7,HP7 #B-B G5E7 T 9CR1SES OXIDATIVE /RESS & D\#S OR TRIPLES _! RISK ( C>DIOVASCUL> 41SE4 ,ISRAELI RESE>*]S F.D T :5 ^! P TOOK #DJJ ,,IU ( VITAM9 ;,E DAILY1 _! RISK ( C>DIOVASCUL> EV5TS S* Z /ROKE1 HE>T ATTACK1 & D1? FELL 0#EJ P]C5T6 ,VITAM9 ;,E'S B5EFITS 7 S PROF.D ! /UDY 0 T]M9AT$ E>LY S ALL /UDY "PICIPANTS CD B5EFIT4 ,O!R /UDIES %[ T VITAM9 ;,E AL PROTECTS AG/ ! ONSET ( DIABETES1 S ,I SU7E/ T "EY"O1 REG>D.S ( H1L? /ATUS1 TAKE AT L1/ #DJJ ,,IU ( NATURAL VITAM9 ;,E E "D4 ,H]BS ,T ,SUPPORT ,H1L?Y ,BLOOD #ED ,GLUCOSE ,LEVELS ,"! >E A FEW H]BS T C HELP MANAGE BLOOD SUG> LEVELS & AL PROTECT AG/ DIABETIC -PLIC,NS4 ,"O IS ,GYMNEMA SYLVE/RE1 AN EXTRACT F ! L1VES (A PLANT NATIVE 6,9DIA T HAS BE5 %[N 6SL[ TRANSPORT ( GLUCOSE F ! 9TE/9ES 6! BLOOD/R1M4 ,? 9 TURN HELPS 6KEEP BLOOD SUG> LEVELS 9 ! H1L?Y RANGE4 ,I RECOMM5D #DJJ MG ( ,GYMNEMA SYLVE/RE DAILY4 ,ANO!R H]B IS BANABA L1F EXTRACT 7,LAG]/ROEMIA SPECIOSA ,L71 : -ES F ,ASIA4 ,BANABA L1F 3TA9S COLOSOLIC ACID1 : PROMOTES GLUCOSE TRANSPORT 96! CELLS1 KEEP+ BLOOD SUG> LEVELS ON AN EV5 KEEL4 ,9 "O ,JAPANESE CL9ICAL TRIAL1 #BD P ) DIABETES 7 GIV5 A SUPPLE;T 3TA9+ BANABA L1F OR A PLACEBO ?REE "TS A "D = F\R WEEKS4 ,:ILE ^? TAK+ ! PLACEBO %[$ NO IMPROVE;T1 SIGNIFICANT BLOOD SUG> DECL9ES 7 OBS]V$ 9 ! 9DIVIDUALS TAK+ ! H]B 7AV]AGE #AEC.I 6#ACC.A MG_/D,L74 ,I RECOMM5D #DH MG ( BANABA L1F DAILY4 .,W>N+3 ,S9CE H]BS H /R;G #EE M$IC9AL E6ECTS ON ! BODY !Y C 9T]ACT ) "S DRUGS 9 WAYS T C 2 DANG]\S 6YR H1L?4 ,"!=E1 IF Y >E TAK+ ANY M$IC,N 7PRESCRIP;N OR OV] ! C.T]7 TALK 6YR DOCTOR OR PH>MACI/ 2F US+ H]BAL PRODUCTS4 ,N\RI% ,YR ,N]VES ,9 A4I;N 6;,B-COMPLEX VITAM9S1 "! >E A C\PLE ( O!R SUPPLE;TS T H BE5 DEMON/RAT$ 6SUPPORT N]VE H1L?4 ,DUE 6! DIABETIC .PP#AB -PLIC,NS ASSOCIAT$ ) IMPAIR$ N]VE FUNC;N 7I4E41 NEUROPA?Y71 ,I REGUL>LY USE ^! T>GET$ SUPPLE;TS ) MY PATI5TS :O >E MONITOR+ _! BLOOD SUG> LEVELS4 ,OV]COM+ ,DIABETIC ,NEUROPA?Y ,) ,,ALA ,! F/ IS LIPOIC ACID1 AL CALL$ ALPHA LIPOIC ACID OR ,,ALA4 ,LIPOIC ACID IS A VITAM9-L ANTIOXIDANT1 REF]R$ 6Z ! 8UNIV]SAL ANTIOXIDANT0 2C X IS BO? FAT- & WAT]-SOLU#4 ,? ALL[S X 65T] ALL "PS (! CELL 6NEUTRALIZE FREE RADICALS4 #EF ,RESE>* HAS %[N T :5 TAK5 9 HI< DOSES1 LIPOIC ACID HELPS 6SUPPORT P]IPH]AL N]VE H1L?4 ,DEP5D+ ON ! AM.T ( SUPPORT Y NE$1 ,I RECOMM5D #FJJ-A1BJJ MG ( LIPOIC ACID P] "D4 ,BILL _H DIABETIC NEUROPA?Y & V LL S5S,N 9 8 H&S OR 2L 8 KNEES4 ,HE 0 3/ANTLY DROPP+ ?+S1 & 8 LEFT LEG DRA7$4 ,8 DOCTOR TOLD HM "! 0 NO HOPE ( IMPROVE;T & PREDICT$ T HE'D 2 9 A :EEL*AIR )9 A YE>4 ,R ?AN A3EPT+ ? DIRE PROGNOSIS1 ,BILL ACT$ ON ADVICE HE'D R1D 9 ,H1L? @& ,H1L+ & />T$ TAK+ ALPHA LIPOIC ACID 7,,ALA74 ,BILL REPORT$ T AF TAK+ ,,ALA = AB TWO MON?S1 8 COORD9,N IMPROV$1 ! PA9 9 8 H&S & FEET RESOLV$1 & 8 GAIT NORMALIZ$4 ,BILL'S DOCTOR SD HE'D N"E SE5 S* A TURN>.D4 ,BILL EV5TU,Y CAME 6! CL9IC & RCVD O!R TR1T;TS1 9CLUD+ ,,EECP1 ,,HBOT1 *EL,N4 & 9FRAR$ LIGET$ NUTRI;NAL SUPPLE;TS4 ,M REC5TLY1 X'S BE5 4COV]$ T #EG 3TROLL$-REL1SE LIPOIC ACID HAS "S ADVANTAGES = PATI5TS ) DIABETES1 S9CE X /AYS 9 ! SY/EM M* L;G]4 ,3TROLL$-REL1SE LIPOIC ACID %D 2 TAK5 9 DIVID$ DOSES HALF AN H\R 6AN H\R 2F EAT+ = OPTIMAL ABSORP;N4 ,USE Z DIRECT$4 ,A GD BR& IS ,,ALAM,'AX ,,CR1 AVAILA# 0CALL+ #HJJ-HAJ-FFEE4 ,QK-REL1SE BR&S >E SOLD 9 H1L? FOOD /ORES4 ,ANO!R SUPPLE;T ,I RECOMM5D = PROMOT+ N]VE H1L? IS EV5+ PRIMROSE OIL 7,,EPO74 ,,EPO1 : 3TA9S ! ESS5TIAL FATTY ACID GAMMA L9OL5IC ACID 7,,GLA71 HAS BE5 %[N 6HELP SUPPORT OPTIMAL N]VE FUNC;N4 ,9 "O D\#-BL /UDY C>RI$ \ 9 SEV5 M$ICAL C5T]S1 #DHJ MG ( EV5+ PRIMROSE OIL TAK5 DAILY = "O YE> PROV$ B5EFICIAL 6PATI5TS' N]VE H1L?4 ,O!R /UDIES H UTILIZ$ DOSES ( UP 6#F1JJJ MG P] "D ) GD RESULTS4 ,I SU7E/ />T+ ) #EJJ-A1EJJ MG P] "D1 & GRADU,Y BUILD+ UP YR DOSE IF NEC4 ,A ,BR1K"? ,BOTANICAL ,) #EH ,MULTIPLE ,B5EFITS ,AN EXTRACT F ,IRV+IA GABON5SIS1 A ,WE/ ,AFRICAN TREE ) $I# FRUIT & SE$S1 "WS ON MULTIPLE FRONTS 6PROMOTE WEIT]S1 X 9HIBITS 5ZYMES T A6ECT BO? ! ABSORP;N ( GLUCOSE 96! BLOOD & XS 3V].N 96TRIGLYC]IDES4 ,"!=E1 X L[]S BLOOD SUG> & REDUCES FAT /ORAGE4 ,B M IMPORTANT1 IRV+IA A6ECTS TWO HORM"OS T >E 9TIMATELY 9VOLV$ 9 WEIE (T5 SKY HI<4 ,T'S 2C OV]WEIK] ( 9FLAMM,N1 ,,CRP B9DS 6LEPT9 & BLOCKS XS E6ECTS ON SATIETY & WEIILY A #EI MODULATOR (! CELLS' S5SITIV;Y 69SUL94 ,! M BODY FAT Y H1 ! L[] YR ADIP"OCT9 LEVEL &! M 9SUL9 RESI/ANT Y >E--: EXPLA9S1 AT L1/ 9 "P1 ! CLOSE REL,N%IP 2T DIABETES & OBES;Y4 ,IRV+IA HAS ! UNIQUE ABIL;Y 6RAISE LEVELS ( ADIP"OCT9 & ?US IMPROVES 9SUL9 S5SITIV;Y & PROMOTES WEIE PROF.D4 ,9 A #BJJH TRIAL1 OV]WEIY OR EX]CISE *ANGES 7 MADE47 ,AT ! /UDY'S 3CLU.N1 ^? :O _H TAK5 IRV+IA LO/ AN AV]AGE ( #BH P.DS1 #AF.B P]C5T ( WAI/ CIRCUMF];E1 & #AH.D P]C5T ( BODY FAT4 ,!Y AL _H /UNN+ REDUC;NS 9 AV]AGE BLOOD SUG> 7#BB P]C5T71 TOTAL *OLE/]OL 7#BF P]C5T71 ,,LDL *OLE/]OL 7#BG P]C5T71 & ,,CRP 7#EB P]C5T74 ,"! 7 NO SIGNIFICANT *ANGES 9 ! PLACEBO GR\P4 ,A GD BR& ( ,IRV+IA GABON5SIS IS ,LIFE ,EXT5.N'S ,9TEGRA-,L1N ,IRV+IA1 AVAILA# ONL9E AT LEF4ORG OR 0CALL+ #HJJ-HAJ-FFEE4 ,TAKE Z DIRECT$4 #FJ ,CAU;N3 ,IF Y'RE TAK+ DRUGS = DIABETES OR *OLE/]OL1 MONITOR YR BLOOD SUG> & *OLE/]OL LEVELS 6MAKE SURE !Y DON'T FALL TOO L[4 .PP#AC ,O!R ,!RAPIES ,:ILE FOLL[+ A PROP] DIET1 TAK+ T>GET$ NUTRI;NAL SUPPLE;TS1 & EX]CIS+ REGUL>LY >E E6ECTIVE WAYS 6NATUR,Y MANAGE DIABETES1 "! >E O!R !RAPIES T WE USE AT ! ,:ITAK] ,WELL;S ,9/ITUTE T >E AL HELP;L4 ,^! TR1T;TS >E ESPECI,Y USE;L = A4RESS+ ! WIDE V>IETY ( -PLIC,NS _M P ) DIABETES EXP]I;E4 ,SUG>3 ,SWEET1 ,P[];L ,M$IC9E ,J]OME1 A S*OOLT1*] ,I SAW M ?AN #BJ YE>S AGO1 0 LY+ 9 A HOSPITAL B$ AWAIT+ A 2L-!-KNEE AMPUT,N1 ?ANKS 6A GANGR5\S ULC] T DIDN'T RESPOND 69TRAV5\S ANTIBIOTICS4 ,AB FIVE H\RS 2F HE 0 S*$UL$ = SURG]Y1 "S"O TOLD ,J]OME AB MY CL9IC4 ,HE *ECK$ \ (! HOSPITAL AG/ #FA M$ICAL ADVICE & CAME 6,:ITAK] ,WELL;S4 ,L ALL \R PATI5TS ) DIABETES1 ,I IMMLY />T$ ,J]OME ON A !RAPEUTIC DIET & NUTRI;NAL SUPPLE;T PROGRAM 7HE 0 OBVI\SLY UNA# 6EX]CISE74 ,HE AL RCVD A C\RSE ( ,,$TA *EL,N4 ,Z =! 9FECT$ ULC]-- : 0 S F> G"O ! SK9 0 ALM BLACK--WE TR1T$ X ) SUG> DRESS+S4 ,Z 9CR$I# Z X MAY SEEM1 WE SIMPLY P\R$ SUG> 96! W.D1 WRAPP$ X UP1 & *ANG$ ! DRESS+ REGUL>LY4 ,)9 "DS ,J]OME NOTIC$ A DI6];E & )9 A FEW WEEKS 8 FOOT 2GAN 6REGA9 XS NORMAL COLOR1 & EV5TU,Y ! W.D -PLETELY H1L$4 ,I'VE BE5 US+ SUG> 6DRESS OP5 W.DS = #BJ YE>S1 B ? !RAPY HAS BE5 >.D = M* L;G]--AT L1/ #E1JJJ YE>S4 ,ANCI5T ,EGYPTIANS1 ,GREEKS1 & ,ROMANS ALL US$ H"OY 7: "WS J L SUG>7 6TR1T OP5 W.DS & BURNS4 ,TD1 ANTIBIOTIC O9T;TS >E ! TR1T;T ( *OICE = ULC]S1 CUTS1 SCRAPES1 & BURNS4 ,YET H"OY & SUG> >E F> SUP]IOR 6ANY ANTIBIOTIC O9T;T "E US$4 ,:5 SUG> OR H"OY IS PACK$ ON TOP (& 9SIDE AN OP5 W.D1 X 4SOLVES 9 ! FLUID EXUD+ F ! W.D1 CR1T+ A #FB HYP]OSMOTIC1 OR HI SOLU;N4 ,9 A4I;N 6CURB+ 9FEC;N1 ? !RAPY FACILITATES H1L+ 9 O!R WAYS4 ,X DRAWS FLUID \ (! W.D1 : REDUCES $EMA 7SWELL+74 ,X PROVIDES A COV]+ OR FILL+ & "!=E PREV5TS SCA2+4 ,X 5C\RAGES ! REMOVAL ( D1D TISSUE 6MAKE WAY = NEW GR[?4 ,X PROMOTES GRANUL,N1 ! =M,N ( 3NECTIVE TISSUE & BLOOD VESSELS ON ! SURFACES (A W.D4 ,F9,Y1 X SUPPORTS ! GR[? ( NEW SK9 COV]+ ! W.D4 ,! NET RESULT IS RAPID H1L+ ) M9IMAL SC>R+4 ,SUG> OR H"OY DRESS+ MAY 2 US$ 6TR1T ANY K9D ( OP5 W.D OR BURN4 7,WE USE SUG> AT ! CL9IC 2C X'S LESS MESSY47 ,X W N "W ON ABSCESSES OR PU/ULES T >E COV]$ ) SK94 ,AL1 D N USE ON A BLE$+ W.D Z #FC SUG> PROMOTES BLE$+4 7,0! WAY1 SUG> & H"OY >E P]FECTLY SAFE 6USE ON DIABETIC W.DS 2C !Y D N 5T] ! BLOOD/R1M47 #A4 ,UNRAVEL A #D 0#D 9* PIECE ( GAUZE 96A L;G /RIP & COAT X ) ,VASEL9E4 ,PLACE X >.D ! \TSIDE $GES (! W.D1 L A DONUT4 #B4 ,COV] ! W.D ) #A_/D 9* ( SUG>4 7,! ,VASEL9E 8DONUT0 W KEEP X 9 PLACE47 #C4 ,PLACE A #D 0#D 9* SP;GE ON TOP (! W.D4 ,B&AGE X FIRMLY B N TOO SNUGLY )A CL+ DRESS+4 #D4 ,*ANGE ! DRESS+ E "O OR TWO "DS4 ,REMOVE1 IRRIGATE ) WAT]1 SAL9E1 OR HYDROG5 P]OXIDE1 PAT DRY1 & REP1T /EPS #A-C4 ,9FRAR$ ,LI DRESS+S1 9FRAR$ LIE A6IX$ OV] ! FEET1 #FD ANKLES1 OR O!R A6ECT$ >1S4 ,! PHOTON 5]GY T PULSES F ! LIE REMOV$4 ,! KEY 6? DRAMATIC IMPROVE;T 9 BLOOD FL[ IS A %ORT-LIV$ MOLECULE CALL$ NITRIC OXIDE4 ,NITRIC OXIDE IS AN UN/A# GAS T IS CRUCIAL 6! H1L? (! C>DIOVASCUL> SY/EM1 & 0EXT5.N1 6E "P (! BODY T DEP5DS ON AN ADEQUATE BLOOD SUPPLY = NORMAL FUNC;N+4 ,?\< NITRIC OXIDE EXI/S = ONLY #AJ SECONDS AF 2+ REL1S$ 0A CELL1 ? P[];L SIGNAL+ MOLECULE HELPS REGULATE BLOOD PRESSURE1 PREV5TS >T]IAL SPASMS1 & 4C\RAGES PLATELETS F CLUMP+ TGR 9 ! BLOOD VESSELS4 ,9 %ORT1 NITRIC OXIDE PROTECTS ! >T]Y .PP#AD WALLS & BOO/S CIRCUL,N1 : BR+S OXYG5 & NUTRI5TS 69JUR$ TISSUES & /IMULATES H1L+4 ,9FRAR$ LIIC ,OXYG5 ,!RAPY ,ANO!R !RAPY ,I USE ) "S ( MY PATI5TS ) DIABETES IS HYP]B>IC OXYG5 !RAPY 7,,HBOT74 ,,HBOT 9VOLVES BR1?+ #AJJ P]C5T OXYG5 9 A PRESSURIZ$ *AMB]4 ,? ALL[S OXYG5 64SOLVE 9 ! PLASMA & O!R FLUIDS1 MAK+ X EASILY A3ESSI# 6ALL TISSUES 9 ! BODY4 ,X IS AN EXCEP;N,Y E6ECTIVE !RAPY T 9CR1SES CIRCUL,N1 FACILITATES NEW BLOOD VESSEL GR[?1 & BOO/S ! PRODUC;N ( GR[? FACTORS NEC = H1L+4 ,X EV5 HELPS /OP ! SPR1D ( 9FEC;N 2C ANAEROBIC BACT]IA _C SURVIVE 9 #FF AN OXYG5-RI* 5VIRON;T1 : MAKES X V USE;L = TR1T+ NON-H1L+ DIABETIC ULC]S4 7,SEE ,RES\RCES SEC;N47 ,HELP ,YRF 6,BETT] ,H1L? ,9 OV] #CJ YE>S ( TR1T+ ?\S&S ( P ) TYPE #B DIABETES1 =! MAJOR;Y1 A7RESSIVE TR1T;T ) DIET1 EX]CISE1 WEI 3TROL4 ,9 FACT1 0ADOPT+ ? NATURAL TR1T;T PROGRAM1 A MAJOR;Y (! PATI5TS :O -E 6! CL9IC ALR TAK+ HYPOGLYCEMIC DRUGS >E SU3ESS;LLY W1N$ F !M4 ,TAKE ! CASE ( ,ALICE1 :O CAME 6! CL9IC )A SEV5-YE> HI/ORY ( TYPE #B DIABETES4 ,H] BLOOD SUG> 0 "U PRETTY GD 3TROL ON A SULFONYLUREA DRUG1 B %E 0 3C]N$ AB SIDE E6ECTS--Z %E %D H BE54 ,DUR+ H] WEEK AT \R ,BACK 6,H1L? PROGRAM1 ,ALICE 0 W1N$ (F ! M$IC,N & PLAC$ ON A -B9,N ( T>GET$ M9]ALS & H]BS4 ,%E REMA9S ON ? E6ECTIVE1 LESS EXP5SIVE1 & F> SAF] PROGRAM1 & H] BLOOD #FG SUG>S 3T9UE 6BE 9 ! NORMAL RANGE4 ,R4,B41 ANO!R TYPE #B DIABETIC1 _H BE5 ON 9SUL9 = #AF YE>S4 ,%E _H RET9OPA?Y1 ANG9A1 HI< BLOOD PRESSURE1 A HI/ORY ( TWO HE>T ATTACKS1 & AN OP5 ULC] ON H] FOOT T REFUS$ 6H1L4 ,B ! MO/ DEBILITAT+ ( H] PRO#MS 0 NEUROPA?Y4 ,N]VE DAMAGE LEFT H] ) VIRTU,Y NO S5S,N 9 H] FEET1 & %E CD B>ELY GET >.D ON H] [N4 ,AF HITT+ ROCK BOTTOM1 ,R4,B4 CAME 6! CL9IC & />T$ ON A -PREH5SIVE NUTRI;NAL REGIM51 : 9CLUD$ HI< DOSES ( ANTIOXIDANTS1 ;,B-COMPLEX VITAM9S1 Z9C1 MAGNESIUM1 & T>GET$ NUTRI5TS & H]BS 6HELP 3TROL H] BLOOD SUG>4 ,GIV5 ! SEV];Y ( H] 3DI;N1 ,R4,B4 AL "UW5T A C\RSE ( ,,EECP & ,,HBOT4 ,)9 ?REE "DS1 ! FEEL+ 2GAN 6RETURN 6H] FEET4 ,%E _H M 5]GY1 LESS PA91 &A RENEW$ S5SE ( HOPE4 ,0! 5D ( H] SECOND WEEK AT ! CL9IC1 %E 0 WALK+ NORM,Y4 ,9 FACT1 %E & H] DAU.D & SIIC OXYG5 !RAPY 7,,HBOT71 OR ,,$TA *EL,N !RAPY1 3TACT ! ,:ITAK] ,WELL;S ,9/ITUTE AT #HJJ-DHH-AEJJ OR WHITAKERWELLNESS.COM4 ,9FRAR$ LIE AVAILA# F A V>IETY ( RETAIL]S4 ,"O GD BR& IS ,H1L?,LI